Q9NQ31Q8NBS2Q8TAC6Q8TAD3Q8TAE0BCA3_HUMANProline-rich protein BCA3Breast cancer-associated gene 3 proteinPKA-interacting proteinAKIP1BCA3C11orf17Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCharacterization of a novel human breast cancer associated gene (BCA3) encoding an alternatively spliced proline-rich protein.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)TISSUE SPECIFICITYLymph nodeComparative genomic sequencing reveals a strikingly similar architecture of a conserved syntenic region on human chromosome 11p15.3 (including gene ST5) and mouse chromosome 7.NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)Complete sequencing and characterization of 21,243 full-length human cDNAs.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)VARIANT LYS-23The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)VARIANT LYS-23KidneyA-kinase-interacting protein localizes protein kinase A in the nucleus.TISSUE SPECIFICITYSUBCELLULAR LOCATIONINTERACTION WITH PRKACAInteracts with PRKACA.P17612false2Nucleus. Note=Locates to punctate spots.Q9NQ31-111aQ9NQ31-22Q9NQ31-331bExpressed at high levels in adult heart and at lower levels in brain, testis, ovary and skeletal muscle. Up-regulated in some breast cancer cell lines. Isoform 1 and isoform 3 are expressed in fetal brain.Alternative splicingNucleusPolymorphismProto-oncogeneRKATFS
MDNCLAAAALNGVDRRSLQRSARLALEVLERAKRRAVDWHALERPKGCMGVLAREAPHLEKQPAAGPQRVLPGEREERPPTLSASFRTMAEFMDYTSSQCGKYYSSVPEEGGATHVYRYHRGESKLHMCLDIGNGQRKDRKKTSLGPGGSYQISEHAPEASQPAENISKDLYIEVYPGTYSVTVGSNDLTKKTHVVAVDSGQSVDLVFPV
Q16821A0AVQ2O43476Q75LN8Q7KYM8Q86UI6PPR3A_HUMANProtein phosphatase 1 regulatory subunit 3AProtein phosphatase 1 glycogen-associated regulatory subunitProtein phosphatase type-1 glycogen targeting subunitPPP1R3APP1GHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoA common variant in PPP1R3 associated with insulin resistance and type 2 diabetes.NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2)TISSUE SPECIFICITYVARIANT INSULIN RESISTANCE TYR-905VARIANT SER-883Skeletal muscleThe DNA sequence of human chromosome 7.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]VARIANTS VAL-451; ASN-476 AND LEU-882The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)Sequence of the human glycogen-associated regulatory subunit of type I protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with non-insulin-dependent diabetes.NUCLEOTIDE SEQUENCE [MRNA] OF 2-1122 (ISOFORM 1)VARIANT NIDDM GLU-931Skeletal muscleGlobal, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-759MASS SPECTROMETRYEpitheliumA widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin.VARIANT INSULIN RESISTANCE TYR-905The consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] ALA-554Seems to act as a glycogen-targeting subunit for PP1. PP1 is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Plays an important role in glycogen synthesis but is not essential for insulin activation of glycogen synthase.Interacts with PPP1CC catalytic subunit of PP1, and associates with glycogen.Membrane; Single-pass membrane protein.Q16821-11Q16821-22No experimental confirmation availableSkeletal muscle and heart.The CBM21 domain is known to be involved in the localization to glycogen and is characteristic of some regulatory subunit of phosphatase complexes.Phosphorylation at Ser-46 by ISPK stimulates the dephosphorylation of glycogen synthase and phosphorylase kinase.Defects in PPP1R3A are a cause of susceptibility to noninsulin-dependent diabetes mellitus (NIDDM) [MIM:125853]; also known as diabetes mellitus type II. NIDDM is characterized by an autosomal dominant mode of inheritance, onset during adulthood and insulin resistance.Defects in PPP1R3A are a cause of insulin resistance (Ins resistance).Contains 1 CBM21 (carbohydrate binding type-21) domain.Alternative splicingCarbohydrate metabolismDiabetes mellitusDisease mutationGlycogen metabolismMembranePhosphoproteinPolymorphismTransmembraneGTRRVSFADSFGFNLERTRAGACKTMERSSGSCYMVKNGAEKHLRSDYAE
MEPSEVPSQISKDNFLEVPNLSDSLCEDEEVTFQPGFSPQPSRRGSDSSEDIYLDTPSSGTRRVSFADSFGFNLVSVKEFDCWELPSASTTFDLGTDIFHTEEYVLAPLFDLPSSKEDLMQQLQIQKAILESTESLLGSTSIKGIIRVLNVSFEKLVYVRMSLDDWQTHYDILAEYVPNSCDGETDQFSFKIVLVPPYQKDGSKVEFCIRYETSVGTFWSNNNGTNYTFICQKKEQEPEPVKPWKEVPNRQIKGCLKVKSSKEESSVTSEENNFENPKNTDTYIPTIICSHEDKEDLEASNRNVKDVNREHDEHNEKELELMINQHLIRTRSTASRDERNTFSTDPVNFPNKAEGLEKKQIHGEICTDLFQRSLSPSSSAESSVKGDFYCNEKYSSGDDCTHQPSEETTSNMGEIKPSLGDTSSDELVQLHTGSKEVLDDNANPAHGNGTMQIPCPSSDQLMAGNLNKKHEGGAKKIEVKDLGCLRRDFHSDTSACLKESTEEGSSKEDYYGNGKDDEEQRIYLGVNEKQRKNFQTILHDQERKMGNPKISVAGIGASNRDLATLLSEHTAIPTRAITADVSHSPRTNLSWEEAVLTPEHHHLTSEGSALGGITGQVCSSRTGNVLRNDYLFQVEEKSGGINSEDQDNSPQHKQSWNVLESQGKSRENKTNITEHIKGQTDCEDVWGKRDNTRSLKATTEELFTCQETVCCELSSLADHGITEKAEAGTAYIIKTTSESTPESMSAREKAIIAKLPQETARSDRPIEVKETAFDPHEGRNDDSHYTLCQRDTVGVIYDNDFEKESRLGICNVRVDEMEKEETMSMYNPRKTHDREKCGTGNITSVEESSWVITEYQKATSKLDLQLGMLPTDKTVFSENRDHRQVQELSKKTDSDAIVHSAFNSDTNRAPQNSSPFSKHHTEISVSTNEQAIAVENAVTTMASQPISTKSENICNSTREIQGIEKHPYPESKPEEVSRSSGIVTSGSRKERCIGQIFQTEEYSVEKSLGPMILINKPLENMEEARHENEGLVSSGQSLYTSGEKESDSSASTSLPVEESQAQGNESLFSKYTNSKIPYFLLFLIFLITVYHYDLMIGLTFYVLSLSWLSWEEGRQKESVKKK
P38936Q14010Q9BUT4CDN1A_HUMANCyclin-dependent kinase inhibitor 1p21CDK-interacting protein 1Melanoma differentiation-associated protein 6MDA-6CDKN1ACAP20CDKN1CIP1MDA6PIC1SDI1WAF1Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.NUCLEOTIDE SEQUENCE [MRNA]WAF1, a potential mediator of p53 tumor suppression.NUCLEOTIDE SEQUENCE [MRNA]p21 is a universal inhibitor of cyclin kinases.NUCLEOTIDE SEQUENCE [MRNA]Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells.NUCLEOTIDE SEQUENCE [MRNA]NUCLEOTIDE SEQUENCECloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.NUCLEOTIDE SEQUENCE [MRNA]Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer.NUCLEOTIDE SEQUENCE [MRNA]VARIANT ARG-31NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).NUCLEOTIDE SEQUENCE [GENOMIC DNA]VARIANT ARG-31The DNA sequence and analysis of human chromosome 6.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]VARIANT ARG-31EyeLungN-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1).PROTEIN SEQUENCE OF 2-16ACETYLATION AT SER-2Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.PROTEIN SEQUENCE OF 136-148PHOSPHORYLATION AT THR-145; SER-146 AND SER-160MASS SPECTROMETRYAkt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells.PHOSPHORYLATION AT THR-145MUTAGENESIS OF THR-145 AND SER-146SUBCELLULAR LOCATIONA probability-based approach for high-throughput protein phosphorylation analysis and site localization.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130MASS SPECTROMETRYEpitheliumStructure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA.X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 139-160May be the important intermediate by which p53 mediates its role as an inhibitor of cellular proliferation in response to DNA damage. Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression.P78396false1P20248false1O95067false1P24385false2P30281false1P24864false3O96020false1O75419false1Q99459false1Q99741false1O00311false1P24941false5P11802false2Q00535false1Q00534false1O75496false1Q7L590false1O94921false4Cytoplasm. Nucleus.Expressed in all adult human tissues, with 5-fold lower levels observed in the brain.By p53, mezerein (antileukemic compound) and interferon beta.Phosphorylation of Thr-145 by Akt or of Ser-146 by PKC impairs binding to PCNA.Belongs to the CDI family.3D-structureAcetylationCell cycleCytoplasmDirect protein sequencingMetal-bindingNucleusPhosphoproteinPolymorphismProtein kinase inhibitorZincZinc-fingerSRDGTATDSASD
MSEPAGDVRQNPCGSKACRRLFGPVDSEQLSRDCDALMAGCIQEARERWNFDFVTETPLEGDFAWERVRGLGLPKLYLPTGPRRGRDELGGGRRPGTSPALLQGTAEEDHVDLSLSCTLVPRSGEQAEGSPGGPGDSQGRKRRQTSMTDFYHSKRRLIFSKRKP
Q9JJR5Q3TR76BCA3_MOUSEProline-rich protein BCA3Breast cancer-associated gene 3 proteinPKA-interacting proteinAKIP1Bca3Mus musculusMouseEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMusComparative genomic sequencing reveals a strikingly similar architecture of a conserved syntenic region on human chromosome 11p15.3 (including gene ST5) and mouse chromosome 7.NUCLEOTIDE SEQUENCEThe transcriptional landscape of the mammalian genome.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]C57BL/6JHeadThymusInteracts with PRKACA.Nucleus (By similarity). Note=Locates to punctate spots.Nucleus
MEYCLAAAALNGVDRRSLQRSARLGREVLERAKRRAVDWHSPERSRGNVGVLYRQGPYQERWSVPGSQRLLGEREERCPTLSSSFGAMAEFMDYTSSQCGKYYLSMPEEGGATHVYRYHRRKPPEMHMYSDTGHSQEQRNCRGETSVGQESIYQTSEHSQESSWPTENISKDLYIEVYPGTYSVTVGSSALSKKTHVVAVDPGQSVDLVFPV
Q96IZ0O75796Q6FHY9Q8N700PAWR_HUMANPRKC apoptosis WT1 regulator proteinProstate apoptosis response 4 proteinPar-4PAWRPAR4Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoA novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.NUCLEOTIDE SEQUENCE [MRNA]SUBCELLULAR LOCATIONTISSUE SPECIFICITYINTERACTION WITH WT1NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]VARIANTS LEU-42; ARG-78; ALA-137 AND ALA-202Cloning of human full-length CDSs in BD Creator(TM) system donor vector.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]VARIANT ARG-78The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]KidneyStructural and functional characterization of the upstream regulatory region of the human gene encoding prostate apoptosis response factor-4.NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-64BloodPar-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.FUNCTION IN APOPTOSIS AND TUMOR REGRESSIONp62 forms a ternary complex with PKCzeta and PAR-4 and antagonizes PAR-4-induced PKCzeta inhibition.INTERACTION WITH SQSTM1 AND PRKCZTHAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.SUBCELLULAR LOCATIONINTERACTION WITH THAP1AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4.INTERACTION WITH AATFPAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein.INTERACTION WITH BACE1Apoptosis by Par-4 in cancer and neurodegenerative diseases.REVIEW ON FUNCTION IN APOPTOSIS AND NEURODEGENERATIVE DISEASESPar-4 inducible apoptosis in prostate cancer cells.REVIEWGlobal proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-226; SER-228; THR-229 AND SER-231MASS SPECTROMETRYPro-apoptopic protein capable of selectively inducing apoptosis in cancer cells, sensitizing the cells to diverse apoptotic stimuli and causing regression of tumors in animal models. Induces apoptosis in certain cancer cells by activation of the Fas prodeath pathway and coparallel inhibition of NF-kappaB transcriptional activity. Inhibits the transcriptional activation and augments the transcriptional repression mediated by WT1. Down-regulates the anti-apoptotic protein BCL2 via its interaction with WT1. Seems also to be a transcriptional repressor by itself. May be directly involved in regulating the amyloid precursor protein (APP) cleavage activity of BACE1.Interacts with WT1, via the C-terminal region. Homooligomer. Interacts also with a wide variety of proteins, such as atypical PKCs, p62, DAPK3 kinase and THAP1. Interacts with actin, AATF, BACE1, SPSB1, SPSB2 AND SPSB4. Component of a ternary complex composed of SQSTM1 and PRKCZ.O43293false1Cytoplasm. Nucleus. Note=Mainly cytoplasmic in absence of apoptosis signal and in normal cells. Nuclear in most cancer cell lines. Nuclear entry seems to be essential but not sufficient for apoptosis (By similarity). Nuclear localization includes nucleoplasm and PML nuclear bodies.Widely expressed. Expression is elevated in various neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer, Parkinson and Huntington diseases and stroke. Down-regulated in several cancers.By apoptosis.The leucine-zipper domain is not essential for apoptosis, but is required for sensitization of cells to exogenous apoptotic insults and for interaction with its partners.The SAC domain is a death-inducing domain selective for apoptosis induction in cancer cells. This domain is essential for nuclear entry, Fas activation, inhibition of NF-kappaB activity and induction of apoptosis in cancer cells.Preferentially phosphorylated at the Thr-163 by PKC in cancer cells.ApoptosisCoiled coilCytoplasmNucleusPhosphoproteinPolymorphismTranscriptionTranscription regulationPLPRGAEAAPPPARIMRT
MATGGYRTSSGLGGSTTDFLEEWKAKREKMRAKQNPPGPAPPGGGSSDAAGKPPAGALGTPAAAAANELNNNLPGGAPAAPAVPGPGGVNCAVGSAMLTRAAPGPRRSEDEPPAASASAAPPPQRDEEEPDGVPEKGKSSGPSARKGKGQIEKRKLREKRRSTGVVNIPAAECLDEYEDDEAGQKERKREDAITQQNTIQNEAVNLLDPGSSYLLQEPPRTVSGRYKSTTSVSEEDVSSRYSRTDRSGFPRYNRDANVSGTLVSSSTLEKKIEDLEKEVVRERQENLRLVRLMQDKEEMIGKLKEEIDLLNRDLDDIEDENEQLKQENKTLLKVVGQLTR
Q9HAT0Q9UF38ROP1A_HUMANRopporin-1ARhophilin-associated protein 1ACancer/testis antigen 91CT91ROPN1ROPN1AHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCloning of a human sperm-specific binding protein of rhophilin and function in spermatogenesis.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)TestisNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)TestisThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)A yeast two-hybrid system using Sp17 identified ropporin as a novel cancer-testis antigen in hematologic malignancies.TISSUE SPECIFICITYPOSSIBLE INTERACTION WITH SPA17DEVELOPMENTAL STAGEIDENTIFICATION AS A CANCER/TESTIS ANTIGENHomodimer. Interacts with AKAP3 and RHPN1 (By similarity). May interact with SPA17.Note=In the sperm tail, found in the principal piece and in the cytoplasmic droplet located at the distal end of the midpiece. Inner surface of the fibrous sheath.Q9HAT0-11Q9HAT0-22No experimental confirmation availableTestis specific in adult. Overexpressed in hematologic tumor cells.Expressed in fetal liver.The RIIa domain mediates interaction with AKAP3.The name 'ropporin' comes from the Japanese word 'oppo' which means 'tail'.Belongs to the ropporin family.Contains 1 RIIa domain.Alternative splicingDYFEALSRGETPPVRERSEREYVLLSRLHPLEDGRRQ RVL
MAQTDKPTCIPPELPKMLKEFAKAAIRVQPQDLIQWAADYFEALSRGETPPVRERSERVALCNRAELTPELLKILHSQVAGRLIIRAEELAQMWKVVNLPTDLFNSVMNVGRFTEEIEWLKFLALACSALGVTITKTLKIVCEVLSCDHNGGSPRIPFSTFQFLYTYIAKVDGEISASHVSRMLNYMEQEVIGPDGIITVNDFTQNPRVQLE
Q12802Q14572Q59FP6Q86W90Q8WXQ6Q96JP6Q96P79Q9Y5T0Q9Y5T6AKP13_HUMANA-kinase anchor protein 13AKAP 13Protein kinase A-anchoring protein 13Breast cancer nuclear receptor-binding auxiliary proteinHuman thyroid-anchoring protein 31Guanine nucleotide exchange factor LbcAKAP-LbcLBC oncogeneP47Lymphoid blast crisis oncogeneNon-oncogenic Rho GTPase-specific GTP exchange factorAKAP13BRXHT31LBCHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoNovel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6)Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)FUNCTIONSUBCELLULAR LOCATIONTISSUE SPECIFICITYINTERACTION WITH ESR1; THRA AND PPARAVARIANT SER-2457TestisActivation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7)ALTERNATIVE SPLICING (ISOFORM 6)FUNCTIONSUBCELLULAR LOCATIONDOMAINTISSUE SPECIFICITYSkeletal muscleERRATUMHt31: the first protein kinase A anchoring protein to integrate protein kinase A and Rho signaling.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)INTERACTION WITH RHOAVARIANTS CYS-574 AND SER-2457AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)FUNCTIONSUBCELLULAR LOCATIONTISSUE SPECIFICITYINTERACTION WITH RHOA; RHOB AND RHOCMUTAGENESIS OF ALA-1251; ILE-1260 AND TYR-2153VARIANTS VAL-624; MET-897 AND SER-2457NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)VARIANTS THR-452; ARG-494; CYS-574; LYS-689; ALA-845; MET-897; ALA-1062; ASN-1086 AND THR-1216LungThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)BrainAssociation of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain.NUCLEOTIDE SEQUENCE [MRNA] OF 754-1768PKA AND RII BINDINGMUTAGENESIS OF ALA-1265ThyroidNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1486-2813 (ISOFORM 4)VARIANT SER-2457BrainThe proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway.FUNCTIONINTERACTION WITH ESR2Lbc proto-oncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2.INTERACTION WITH NME2Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1929 AND SER-1932MASS SPECTROMETRYEpitheliumA probability-based approach for high-throughput protein phosphorylation analysis and site localization.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-983 AND SER-2728MASS SPECTROMETRYEpitheliumA novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes.STRUCTURE BY NMR OF 493-516Anchors cAMP-dependent protein kinase (PKA) and acts as an adapter protein to selectively couple G alpha-13 and Rho. Augments gene activation by the estrogen receptor in an element-specific and ligand-dependent manner. Activates estrogen receptor beta by a p38 MAPK-dependent pathway. Isoform 6 stimulates exchange activity on Rho proteins in vitro, but not on CDC42, Ras or Rac and may bind calcium ions.Binds cAMP-dependent protein kinase (PKA) and to the RII-alpha regulatory subunit of PKA. Interacts with ESR1, ESR2, THRA, PPARA, RHOA and NME2.Q16611false1P21980false3P31946false1Isoform 3: Cytoplasm. Nucleus.Isoform 2: Cytoplasm.Isoform 6: Cytoplasm.Isoform 7: Membrane.Q12802-11Q12802-22Q12802-33Q12802-44Q12802-55Q12802-66LBCQ12802-77Isoform 3 and isoform 6 are found in hematopoietic cells, skeletal muscle, lung, heart, estrogen-responsive reproductive tissues, including breast ductal epithelium. Also found in testis and breast cancer cell lines. Isoform 6 is not found in brain, placenta, liver, pancreas or kidney. Isoform 7 is expressed in myeloid and lymphoid lineages, a variety of epithelial tissues and skeletal muscle. Isoform 2 is predominantly found in the heart and at lower levels in the lung, placenta, kidney, pancreas, skeletal muscle and liver.Both the DH and PH domains are required for transforming activity.Contains 1 DH (DBL-homology) domain.Contains 1 PH domain.Contains 1 phorbol-ester/DAG-type zinc finger.3D-structureAlternative splicingCoiled coilCytoplasmGuanine-nucleotide releasing factorMembraneMetal-bindingNucleusPhorbol-ester bindingPhosphoproteinPolymorphismProto-oncogeneZincZinc-fingerDAGPRETLMHFAVRLGLLRLGENLYDLQTHFKFVIFL LFFTQAMLYSMRVLGDVVRRPPIHRMSWCPSGVQYSAGLSADFNYNRDEDEGIPSGNGWRCFNMTWRRCGVEKVAVMPADNMTGSATAPIPAPYFGRCRAVATSPDAMSNHVDDGQLHV
MKLNPQQAPLYGDCVVTVLLAEEDKAEDDVVFYLVFLGSTLRHCTSTRKVSSDTLETIAPGHDCCETVKVQLCASKEGLPVFVVAEEDFHFVQDEAYDAAQFLATSAGNQQALNFTRFLDQSGPPSGDVNSLDKKLVLAFRHLKLPTEWNVLGTDQSLHDAGPRETLMHFAVRLGLLRLTWFLLQKPGGRGALSIHNQEGATPVSLALERGYHKLHQLLTEENAGEPDSWSSLSYEIPYGDCSVRHHRELDIYTLTSESDSHHEHPFPGDGCTGPIFKLMNIQQQLMKTNLKQMDSLMPLMMTAQDPSSAPETDGQFLPCAPEPTDPQRLSSSEETESTQCCPGSPVAQTESPCDLSSIVEEENTDRSCRKKNKGVERKGEEVEPAPIVDSGTVSDQDSCLQSLPDCGVKGTEGLSSCGNRNEETGTKSSGMPTDQESLSSGDAVLQRDLVMEPGTAQYSSGGELGGISTTNVSTPDTAGEMEHGLMNPDATVWKNVLQGGESTKERFENSNIGTAGASDVHVTSKPVDKISVPNCAPAASSLDGNKPAESSLAFSNEETSTEKTAETETSRSREESADAPVDQNSVVIPAAAKDKISDGLEPYTLLAAGIGEAMSPSDLALLGLEEDVMPHQNSETNSSHAQSQKGKSSPICSTTGDDKLCADSACQQNTVTSSGDLVAKLCDNIVSESESTTARQPSSQDPPDASHCEDPQAHTVTSDPVRDTQERADFCPFKVVDNKGQRKDVKLDKPLTNMLEVVSHPHPVVPKMEKELVPDQAVISDSTFSLANSPGSESVTKDDALSFVPSQKEKGTATPELHTATDYRDGPDGNSNEPDTRPLEDRAVGLSTSSTAAELQHGMGNTSLTGLGGEHEGPAPPAIPEALNIKGNTDSSLQSVGKATLALDSVLTEEGKLLVVSESSAAQEQDKDKAVTCSSIKENALSSGTLQEEQRTPPPGQDTQQFHEKSISADCAKDKALQLSNSPGASSAFLKAETEHNKEVAPQVSLLTQGGAAQSLVPPGASLATESRQEALGAEHNSSALLPCLLPDGSDGSDALNCSQPSPLDVGVKNTQSQGKTSACEVSGDVTVDVTGVNALQGMAEPRRENISHNTQDILIPNVLLSQEKNAVLGLPVALQDKAVTDPQGVGTPEMIPLDWEKGKLEGADHSCTMGDAEEAQIDDEAHPVLLQPVAKELPTDMELSAHDDGAPAGVREVMRAPPSGRERSTPSLPCMVSAQDAPLPKGADLIEEAASRIVDAVIEQVKAAGALLTEGEACHMSLSSPELGPLTKGLESAFTEKVSTFPPGESLPMGSTPEEATGSLAGCFAGREEPEKIILPVQGPEPAAEMPDVKAEDEVDFRASSISEEVAVGSIAATLKMKQGPMTQAINRENWCTIEPCPDAASLLASKQSPECENFLDVGLGRECTSKQGVLKRESGSDSDLFHSPSDDMDSIIFPKPEEEHLACDITGSSSSTDDTASLDRHSSHGSDVSLSQILKPNRSRDRQSLDGFYSHGMGAEGRESESEPADPGDVEEEEMDSITEVPANCSVLRSSMRSLSPFRRHSWGPGKNAASDAEMNHRSSMRVLGDVVRRPPIHRRSFSLEGLTGGAGVGNKPSSSLEVSSANAEELRHPFSGEERVDSLVSLSEEDLESDQREHRMFDQQICHRSKQQGFNYCTSAISSPLTKSISLMTISHPGLDNSRPFHSTFHNTSANLTESITEENYNFLPHSPSKKDSEWKSGTKVSRTFSYIKNKMSSSKKSKEKEKEKDKIKEKEKDSKDKEKDKKTVNGHTFSSIPVVGPISCSQCMKPFTNKDAYTCANCSAFVHKGCRESLASCAKVKMKQPKGSLQAHDTSSLPTVIMRNKPSQPKERPRSAVLLVDETATTPIFANRRSQQSVSLSKSVSIQNITGVGNDENMSNTWKFLSHSTDSLNKISKVNESTESLTDEGVGTDMNEGQLLGDFEIESKQLEAESWSRIIDSKFLKQQKKDVVKRQEVIYELMQTEFHHVRTLKIMSGVYSQGMMADLLFEQQMVEKLFPCLDELISIHSQFFQRILERKKESLVDKSEKNFLIKRIGDVLVNQFSGENAERLKKTYGKFCGQHNQSVNYFKDLYAKDKRFQAFVKKKMSSSVVRRLGIPECILLVTQRITKYPVLFQRILQCTKDNEVEQEDLAQSLSLVKDVIGAVDSKVASYEKKVRLNEIYTKTDSKSIMRMKSGQMFAKEDLKRKKLVRDGSVFLKNAAGRLKEVQAVLLTDILVFLQEKDQKYIFASLDQKSTVISLKKLIVREVAHEEKGLFLISMGMTDPEMVEVHASSKEERNSWIQIIQDTINTLNRDEDEGIPSENEEEKKMLDTRARELKEQLHQKDQKILLLLEEKEMIFRDMAECSTPLPEDCSPTHSPRVLFRSNTEEALKGGPLMKSAINEVEILQGLVSGNLGGTLGPTVSSPIEQDVVGPVSLPRRAETFGGFDSHQMNASKGGEKEEGDDGQDLRRTESDSGLKKGGNANLVFMLKRNSEQVVQSVVHLYELLSALQGVVLQQDSYIEDQKLVLSERALTRSLSRPSSLIEQEKQRSLEKQRQDLANLQKQQAQYLEEKRRREREWEARERELREREALLAQREEEVQQGQQDLEKEREELQQKKGTYQYDLERLRAAQKQLEREQEQLRREAERLSQRQTERDLCQVSHPHTKLMRIPSFFPSPEEPPSPSAPSIAKSGSLDSELSVSPKRNSISRTHKDKGPFHILSSTSQTNKGPEGQSQAPASTSASTRLFGLTKPKEKKEKKKKNKTSRSQPGDGPASEVSAEGEEIFC
O75952Q8WXW5Q9HAY3Q9HAY4Q9HAY5Q9HCY9CABYR_HUMANCalcium-binding tyrosine phosphorylation-regulated proteinCalcium-binding protein 86Testis-specific calcium-binding protein CBP86Fibrousheathin-2FSP-2Fibrousheathin IICancer/testis antigen 88CT88CABYRCBP86FSP2Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCABYR, a novel calcium-binding tyrosine phosphorylation-regulated fibrous sheath protein involved in capacitation.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6)PROTEIN SEQUENCE OF 8-23; 28-48; 379-388 AND 394-410VARIANTS ARG-448 AND ALA-490CALCIUM-BINDINGPHOSPHORYLATIONSUBCELLULAR LOCATIONTISSUE SPECIFICITYTestisThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)OvaryPhosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-359; SER-362; SER-413; SER-461 AND SER-469MASS SPECTROMETRYSpermCharacterization of two non-testis-specific CABYR variants that bind to GSK3beta with a proline-rich extensin-like domain.ALTERNATIVE SPLICING (ISOFORMS 3 AND 5)SUBUNITINTERACTION WITH GSK3BPHOSPHORYLATION AT THR-151 AND SER-155MUTAGENESIS OF THR-146; THR-151; SER-154; SER-155 AND THR-159SUBCELLULAR LOCATIONTISSUE SPECIFICITYTranslation and assembly of CABYR coding region B in fibrous sheath and restriction of calcium binding to coding region A.CALCIUM-BINDINGSUBCELLULAR LOCATIONTISSUE SPECIFICITYMay function as a regulator of both motility- and head-associated functions such as capacitation and the acrosome reaction. Isoform 1 binds calcium in vitro. Isoform 2 and isoform 6 probably bind calcium. Isoform 3 and isoform 5 do not bind calcium in vitro. Isoform 4 probably does not bind calcium.Isoform 3 self-associates. Isoform 3 and isoform 5 interact with GSK3B. Isoform 1 does not interact with GSK3B.Cytoplasm. Note=Localized to fibrous sheath including the surface of the longitudinal columns and ribs of the principal piece of sperm flagella. According to Ref.4, isoform 1, isoform 3 and isoform 5 are both nuclear and cytoplasmic.Isoform 1: Nucleus. Cytoplasm. Note=According to Ref.4, isoform 1, isoform 3 and isoform 5 are both nuclear and cytoplasmic.Isoform 3: Nucleus. Cytoplasm. Note=According to Ref.4, isoform 1, isoform 3 and isoform 5 are both nuclear and cytoplasmic.Isoform 5: Nucleus. Cytoplasm. Note=According to Ref.4, isoform 1, isoform 3 and isoform 5 are both nuclear and cytoplasmic.O75952-11O75952-22CBP86-VIIO75952-33CBP86-IIO75952-44CBP86-IVO75952-55CBP86-IIIO75952-66CBP86-VIExpressed in elongating spermatids and spermatozoa (at protein level). Isoform 1 is expressed in testis. Isoform 3 and isoform 5 are also expressed in brain, pancreas and numerous brain tumors.Isoform 1 is phosphorylated on tyrosine residues during in vitro capacitation. Isoform 3 and isoform 5 are phosphorylated by GSK3B in vitro. Dephosphorylation affects its ability to bind calcium.Contains 1 RIIa domain.Alternative splicingCalciumCytoplasmCytoskeletonDirect protein sequencingMetal-bindingNucleusPhosphoproteinPolymorphismStructural proteinGKVSSIHSDQSDVLMVDVATSMPVVIKEVPSSEAAEDVMVAAPLVCSGKVLEVQVVNQTSVHVDLGSQPKENEAEPSTASSVPLQDEQEPPAYDQAPEVTLQADIEVMSTVHISSVYNDVPVTEGVVYIEQLPEQIVIPFTDQVACLKENEQSKENEQSPRVSPKSVVEKTTSGMSKKSVESVKLAQLEENAKYSSVYMAM ATSERGQPPPCSNMWTLYCLTDKNQQGHPSPPPAPGPFPQA TLYLPNPKDPQFQQHPPKVTFPTYVMGDTKKTSAPPFILVG SNVQEAQGWKPLPGHAVVSQSDVLRYVAMQVPIAVPADEKY QKHTLSPQNANPPSGQDVPRPKSPVFLSVAFPVEDVAKKSS GSGDKCAPFGSYGIAGEVTVTTAHKRRKAETENGKVSSIHSDQSDVLMVDVATSMPVVIKEVPSSEAAEDVMVAEDVAKKSSGSGDKCAPFGSYGIAGEVTVTTAHKRRKAE TENTMKRSATATASASATAIV
MISSKPRLVVPYGLKTLLEGISRAVLKTNPSNINQFAAAYFQELTMYRGNTTMDIKDLVKQFHQIKVEKWSEGTTPQKKLECLKEPGKTSVESKVPTQMEKSTDTDEDNVTRTEYSDKTTQFPSVYAVPGTEQTEAVGGLSSKPATPKTTTPPSSPPPTAVSPEFAYVPADPAQLAAQMLGKVSSIHSDQSDVLMVDVATSMPVVIKEVPSSEAAEDVMVAAPLVCSGKVLEVQVVNQTSVHVDLGSQPKENEAEPSTASSVPLQDEQEPPAYDQAPEVTLQADIEVMSTVHISSVYNDVPVTEGVVYIEQLPEQIVIPFTDQVACLKENEQSKENEQSPRVSPKSVVEKTTSGMSKKSVESVKLAQLEENAKYSSVYMEAEATALLSDTSLKGQPEVPAQLLDAEGAIKIGSEKSLHLEVEITSIVSDNTGQEESGENSVPQEMEGKPVLSGEAAEAVHSGTSVKSSSGPFPPAPEGLTAPEIEPEGESTAE
Q15831STK11_HUMANSerine/threonine-protein kinase 11Serine/threonine-protein kinase LKB1Renal carcinoma antigen NY-REN-19STK11LKB1PJSHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoNUCLEOTIDE SEQUENCE [MRNA]LiverPeutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.NUCLEOTIDE SEQUENCE [MRNA]LiverLow frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.NUCLEOTIDE SEQUENCE [GENOMIC DNA]The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]LungUterusAntigens recognized by autologous antibody in patients with renal-cell carcinoma.IDENTIFICATION AS A RENAL CANCER ANTIGENRenal cell carcinomaActivation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD.FUNCTIONSUBCELLULAR LOCATIONINTERACTION WITH STRADAUTOPHOSPHORYLATION AT THR-336 AND THR-363MUTAGENESIS OF ASP-176MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm.FUNCTIONSUBCELLULAR LOCATIONMUTAGENESIS OF ASP-194INTERACTION WITH STRAD AND CAB39Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors.VARIANT TESTICULAR TUMORS ASP-163Nine novel germline mutations of STK11 in ten families with Peutz-Jeghers syndrome.VARIANT PJS ASN-247 DELA serine/threonine kinase gene defective in Peutz-Jeghers syndrome.VARIANTS PJS PRO-67 AND 303-ILE--GLN-306 DELINS ASNNovel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families.VARIANTS PJS 162-ASN--MET-164; ASN-194 AND LYS-297Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer.CHARACTERIZATION OF VARIANT TESTICULAR TUMORS ASP-163Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas.VARIANTS MELANOMA ASP-49 AND ARG-135Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.VARIANT MELANOMA TYR-194Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz-Jeghers syndrome patients.VARIANTS PJS CYS-239 AND SER-315Essential role in G1 cell cycle arrest. Phosphorylates and activates members of the AMPK-related subfamily of protein kinases. Tumor suppressor.ATP + a protein = ADP + a phosphoprotein.Magnesium or Manganese.Activated by binding of a complex consisting of CAB39 and STRAD or CAB39 and ALS2CR2.Q9C0K7false1Q9Y376false1Q96L34false1Q7RTN6false3Nucleus. Cytoplasm. Note=Relocates to the cytoplasm when bound to CAB39 and STRAD or CAB39 and ALS2CR2.Ubiquitously expressed. Strongest expression in testis and fetal liver.Phosphorylated by a cAMP-dependent protein kinase.Defects in STK11 are a cause of Peutz-Jeghers syndrome (PJS) [MIM:175200]. PJS is a rare hereditary disease in which there is predisposition to benign and malignant tumors of many organ systems. PJS is an autosomal dominant disorder characterized by melanocytic macules of the lips, multiple gastrointestinal hamartomatous polyps and an increased risk for various neoplasms, including gastrointestinal cancer.Defects in STK11 have been associated with testicular tumors [MIM:273300]. It includes germ cell tumor (GCT) or testicular germ cell tumor (TGCT).Belongs to the protein kinase superfamily. Ser/Thr protein kinase family.Contains 1 protein kinase domain.PJS entryATP-bindingCell cycleCytoplasmDisease mutationKinaseMagnesiumManganeseMetal-bindingNucleotide-bindingNucleusPhosphoproteinSerine/threonine-protein kinaseTransferaseYDLPGRDGLNDMGDDNDYWCRKIRQHNPSDYDA
MEVVDPQQLGMFTEGELMSVGMDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISDLGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLHGADEDEDLFDIEDDIIYTQDFTVPGQVPEEEASHNGQRRGLPKAVCMNGTEAAQLSTKSRAEGRAPNPARKACSASSKIRRLSACKQQ
O43823AKAP8_HUMANA-kinase anchor protein 8A-kinase anchor protein 95 kDaAKAP 95AKAP8AKAP95Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoMolecular cloning, chromosomal localization, and cell cycle-dependent subcellular distribution of the A-kinase anchoring protein, AKAP95.NUCLEOTIDE SEQUENCE [MRNA]CerebellumTestisThe DNA sequence and biology of human chromosome 19.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]Large-scale characterization of HeLa cell nuclear phosphoproteins.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328MASS SPECTROMETRYEpitheliumGlobal, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323; SER-328 AND SER-339MASS SPECTROMETRYEpitheliumA probability-based approach for high-throughput protein phosphorylation analysis and site localization.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112MASS SPECTROMETRYEpitheliumThe consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] HIS-664Anchoring protein that mediates the subcellular compartmentation of cAMP-dependent protein kinase (PKA type II).Binds to dimeric RII-alpha regulatory subunit of PKA during mitosis.Nucleus matrix. Note=Associated with the nuclear matrix. Redistributed and detached from condensed chromatin during mitosis.Highly expressed in heart, liver, skeletal muscle, kidney and pancreas.Belongs to the AKAP95 family.DNA-bindingMetal-bindingNucleusPhosphoproteinPolymorphismRepeatZincZinc-fingerQH
MDQGYGGYGAWSAGPANTQGAYGTGVASWQGYENYNYYGAQNTSVTTGATYSYGPASWEAAKANDGGLAAGAPAMHMASYGPEPCTDNSDSLIAKINQRLDMMSKEGGRGGSGGGGEGIQDRESSFRFQPFESYDSRPCLPEHNPYRPSYSYDYEFDLGSDRNGSFGGQYSECRDPARERGSLDGFMRGRGQGRFQDRSNPGTFMRSDPFVPPAASSEPLSTPWNELNYVGGRGLGGPSPSRPPPSLFSQSMAPDYGVMGMQGAGGYDSTMPYGCGRSQPRMRDRDRPKRRGFDRFGPDGTGRKRKQFQLYEEPDTKLARVDSEGDFSENDDAAGDFRSGDEEFKGEDELCDSGRQRGEKEDEDEDVKKRREKQRRRDRTRDRAADRIQFACSVCKFRSFDDEEIQKHLQSKFHKETLRFISTKLPDKTVEFLQEYIVNRNKKIEKRRQELMEKETAKPKPDPFKGIGQEHFFKKIEAAHCLACDMLIPAQPQLLQRHLHSVDHNHNRRLAAEQFKKTSLHVAKSVLNNRHIVKMLEKYLKGEDPFTSETVDPEMEGDDNLGGEDKKETPEEVAADVLAEVITAAVRAVDGEGAPAPESSGEPAEDEGPTDTAEAGSDPQAEQLLEEQVPCGTAHEKGVPKARSEAAEAGNGAETMAAEAESAQTRVAPAPAAADAEVEQTDAESKDAVPTE
P61224P09526Q6DCA1Q6LES0RAP1B_HUMANRas-related protein Rap-1b precursorGTP-binding protein smg p21BRAP1BOK/SW-cl.11Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoNucleotide sequence of a human cDNA encoding a ras-related protein (rap1B).NUCLEOTIDE SEQUENCE [MRNA]NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]UterusIdentification of immuno-peptidmics that are recognized by tumor-reactive CTL generated from TIL of colon cancer patients.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]Colon adenocarcinomacDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]BrainCloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]PlacentaTestisPurification and characterization of the 22,000-dalton GTP-binding protein substrate for ADP-ribosylation by botulinum toxin, G22K.PROTEIN SEQUENCE OF 1-35SUBCELLULAR LOCATIONADP-RIBOSYLATION AT SER-39Rap1-B is phosphorylated by protein kinase A in intact human platelets.PROTEIN SEQUENCE OF 146-180PHOSPHORYLATIONExploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.PROTEIN SEQUENCE OF 168-176PlateletPosttranslationally processed structure of the human platelet protein smg p21B: evidence for geranylgeranylation and carboxyl methylation of the C-terminal cysteine.ISOPRENYLATION AT CYS-181PlateletIdentification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway.INTERACTION WITH SGSM1; SGSM2 AND SGSM3Activated by guanine nucleotide-exchange factor (GEF) EPAC2 in a cAMP-dependent manner.Interacts with SGSM1, SGSM2 and SGSM3.Cell membrane. Cytoplasm, cytosol. Note=May shuttle between plasma membrane and cytosol.Belongs to the small GTPase superfamily. Ras family.ADP-ribosylationCytoplasmDirect protein sequencingGTP-bindingLipoproteinMembraneMethylationNucleotide-bindingPhosphoproteinPrenylationKN
MREYKLVVLGSGGVGKSALTVQFVQGIFVEKYDPTIEDSYRKQVEVDAQQCMLEILDTAGTEQFTAMRDLYMKNGQGFALVYSITAQSTFNDLQDLREQILRVKDTDDVPMILVGNKCDLEDERVVGKEQGQNLARQWNNCAFLESSAKSKINVNEIFYDLVRQINRKTPVPGKARKKSSCQLL
Q99996O14869O43355O94895Q75N20Q9UQH3Q9UQQ4Q9Y6B8Q9Y6Y2AKAP9_HUMANA-kinase anchor protein 9Protein kinase A-anchoring protein 9PRKA9A-kinase anchor protein 450 kDaAKAP 450A-kinase anchor protein 350 kDaAKAP 350hgAKAP 350AKAP 120-like proteinProtein hyperionProtein yotiaoCentrosome- and Golgi-localized PKN-associated proteinCG-NAPAKAP9AKAP350AKAP450KIAA0803Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoYotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)BrainCloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)VARIANT GLN-1347 INSCharacterization of a novel giant scaffolding protein, CG-NAP, that anchors multiple signaling enzymes to centrosome and the Golgi apparatus.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)VARIANTS ILE-475 AND SER-2983BrainCloning of Hyperion.NUCLEOTIDE SEQUENCE [GENOMIC DNA]The DNA sequence of human chromosome 7.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]AKAP350, a multiply spliced protein kinase A-anchoring protein associated with centrosomes.NUCLEOTIDE SEQUENCE [MRNA] OF 323-3911 (ISOFORM 2)NUCLEOTIDE SEQUENCE [MRNA] OF 2157-3911 (ISOFORM 6)VARIANT SER-2983Gastric parietal cellLungPrediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2212-3911 (ISOFORMS 2/3)VARIANT SER-2983BrainAKAP350 interaction with cdc42 interacting protein 4 at the Golgi apparatus.FUNCTIONINTERACTION WITH CIP4 AND FNBP1SUBCELLULAR LOCATIONATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3869MASS SPECTROMETRYThe consensus coding sequences of human breast and colorectal cancers.VARIANTS [LARGE SCALE ANALYSIS] ILE-2421 AND GLN-3301Binds to type II regulatory subunits of protein kinase A. Scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. May be required to maintain the integrity of the Golgi apparatus. Isoform 4/Yotiao is associated with the N-methyl-D-aspartate receptor and is specifically found in the neuromuscular junction (NMJ) as well as in neuronal synapses, suggesting a role in the organization of postsynaptic specializations.Interacts with the regulatory region of protein kinase N (PKN), protein phosphatase 2A (PP2A), protein phosphatase 1 (PP1) and the immature non-phosphorylated form of PKC epsilon. Interacts with CIP4 and FNBP1.Cytoplasm. Centrosome. Golgi apparatus. Note=Cytoplasmic in parietal cells.Q99996-11Q99996-22Q99996-33CG-NAPQ99996-44YotiaoQ99996-55Q99996-66AKAP350Widely expressed. Isoform 4/Yotiao is highly expressed in skeletal muscle and in pancreas.RII-binding site, predicted to form an amphipathic helix, could participate in protein-protein interactions with a complementary surface on the R-subunit dimer.Phosphorylated upon DNA damage, probably by ATM or ATR.Alternative splicingCoiled coilCytoplasmGolgi apparatusPhosphoproteinPolymorphismQLQEEIKLAQVRVLSADTFQKVEQVFGFYNMCFSTLCGSSIPELAHSDAYQTREICSSSTTQFHAGMRRALSLTTSWQHHSARPTAPLFFEILSH SLGMIKKQMINSPSEQEQEGRSNSHNKNQKHPKPQPQPNDVERPNTVGAPIVVDEIHEEVLRINEDQHQHESEQSQPATS
MEDEERQKKLEAGKAKIEELSLAFLVRQLAQFRQRKAQSDGQSPSKKQKKKRKTSSSKHDVSAHHDLNIDQSQCNEMYINSSQRVESTVIPESTIMRTLHSGEITSHEQGFSVELESEISTTADDCSSEVNGCSFVMRTGKPTNLLREEEFGVDDSYSEQGAQDSPTHLEMMESELAGKQHEIEELNRELEEMRVTYGTEGLQQLQEFEAAIKQRDGIITQLTANLQQARREKDETMREFLELTEQSQKLQIQFQQLQASETLRNSTHSSTAADLLQAKQQILTHQQQLEEQDHLLEDYQKKKEDFTMQISFLQEKIKVYEMEQDKKVENSNKEEIQEKETIIEELNTKIIEEEKKTLELKDKLTTADKLLGELQEQIVQKNQEIKNMKLELTNSKQKERQSSEEIKQLMGTVEELQKRNHKDSQFETDIVQRMEQETQRKLEQLRAELDEMYGQQIVQMKQELIRQHMAQMEEMKTRHKGEMENALRSYSNITVNEDQIKLMNVAINELNIKLQDTNSQKEKLKEELGLILEEKCALQRQLEDLVEELSFSREQIQRARQTIAEQESKLNEAHKSLSTVEDLKAEIVSASESRKELELKHEAEVTNYKIKLEMLEKEKNAVLDRMAESQEAELERLRTQLLFSHEEELSKLKEDLEIEHRINIEKLKDNLGIHYKQQIDGLQNEMSQKIETMQFEKDNLITKQNQLILEISKLKDLQQSLVNSKSEEMTLQINELQKEIEILRQEEKEKGTLEQEVQELQLKTELLEKQMKEKENDLQEKFAQLEAENSILKDEKKTLEDMLKIHTPVSQEERLIFLDSIKSKSKDSVWEKEIEILIEENEDLKQQCIQLNEEIEKQRNTFSFAEKNFEVNYQELQEEYACLLKVKDDLEDSKNKQELEYKSKLKALNEELHLQRINPTTVKMKSSVFDEDKTFVAETLEMGEVVEKDTTELMEKLEVTKREKLELSQRLSDLSEQLKQKHGEISFLNEEVKSLKQEKEQVSLRCRELEIIINHNRAENVQSCDTQVSSLLDGVVTMTSRGAEGSVSKVNKSFGEESKIMVEDKVSFENMTVGEESKQEQLILDHLPSVTKESSLRATQPSENDKLQKELNVLKSEQNDLRLQMEAQRICLSLVYSTHVDQVREYMENEKDKALCSLKEELIFAQEEKIKELQKIHQLELQTMKTQETGDEGKPLHLLIGKLQKAVSEECSYFLQTLCSVLGEYYTPALKCEVNAEDKENSGDYISENEDPELQDYRYEVQDFQENMHTLLNKVTEEYNKLLVLQTRLSKIWGQQTDGMKLEFGEENLPKEETEFLSIHSQMTNLEDIDVNHKSKLSSLQDLEKTKLEEQVQELESLISSLQQQLKETEQNYEAEIHCLQKRLQAVSESTVPPSLPVDSVVITESDAQRTMYPGSCVKKNIDGTIEFSGEFGVKEETNIVKLLEKQYQEQLEEEVAKVIVSMSIAFAQQTELSRISGGKENTASSKQAHAVCQQEQHYFNEMKLSQDQIGFQTFETVDVKFKEEFKPLSKELGEHGKEILLSNSDPHDIPESKDCVLTISEEMFSKDKTFIVRQSIHDEISVSSMDASRQLMLNEEQLEDMRQELVRQYQEHQQATELLRQAHMRQMERQREDQEQLQEEIKRLNRQLAQRSSIDNENLVSERERVLLEELEALKQLSLAGREKLCCELRNSSTQTQNGNENQGEVEEQTFKEKELDRKPEDVPPEILSNERYALQKANNRLLKILLEVVKTTAAVEETIGRHVLGILDRSSKSQSSASLIWRSEAEASVKSCVHEEHTRVTDESIPSYSGSDMPRNDINMWSKVTEEGTELSQRLVRSGFAGTEIDPENEELMLNISSRLQAAVEKLLEAISETSSQLEHAKVTQTELMRESFRQKQEATESLKCQEELRERLHEESRAREQLAVELSKAEGVIDGYADEKTLFERQIQEKTDIIDRLEQELLCASNRLQELEAEQQQIQEERELLSRQKEAMKAEAGPVEQQLLQETEKLMKEKLEVQCQAEKVRDDLQKQVKALEIDVEEQVSRFIELEQEKNTELMDLRQQNQALEKQLEKMRKFLDEQAIDREHERDVFQQEIQKLEQQLKVVPRFQPISEHQTREVEQLANHLKEKTDKCSELLLSKEQLQRDIQERNEEIEKLEFRVRELEQALLVSADTFQKVEDRKHFGAVEAKPELSLEVQLQAERDAIDRKEKEITNLEEQLEQFREELENKNEEVQQLHMQLEIQKKESTTRLQELEQENKLFKDDMEKLGLAIKESDAMSTQDQHVLFGKFAQIIQEKEVEIDQLNEQVTKLQQQLKITTDNKVIEEKNELIRDLETQIECLMSDQECVKRNREEEIEQLNEVIEKLQQELANIGQKTSMNAHSLSEEADSLKHQLDVVIAEKLALEQQVETANEEMTFMKNVLKETNFKMNQLTQELFSLKRERESVEKIQSIPENSVNVAIDHLSKDKPELEVVLTEDALKSLENQTYFKSFEENGKGSIINLETRLLQLESTVSAKDLELTQCYKQIKDMQEQGQFETEMLQKKIVNLQKIVEEKVAAALVSQIQLEAVQEYAKFCQDNQTISSEPERTNIQNLNQLREDELGSDISALTLRISELESQVVEMHTSLILEKEQVEIAEKNVLEKEKKLLELQKLLEGNEKKQREKEKKRSPQDVEVLKTTTELFHSNEESGFFNELEALRAESVATKAELASYKEKAEKLQEELLVKETNMTSLQKDLSQVRDHLAEAKEKLSILEKEDETEVQESKKACMFEPLPIKLSKSIASQTDGTLKISSSNQTPQILVKNAGIQINLQSECSSEEVTEIISQFTEKIEKMQELHAAEILDMESRHISETETLKREHYVAVQLLKEECGTLKAVIQCLRSKEVFGFYNMCFSTLCDSGSDWGQGIYLTHSQGFDIASEGRGEESESATDSFPKKIKGLLRAVHNEGMQVLSLTESPYSDGEDHSIQQVSEPWLEERKAYINTISSLKDLITKMQLQREAEVYDSSQSHESFSDWRGELLLALQQVFLEERSVLLAAFRTELTALGTTDAVGLLNCLEQRIQEQGVEYQAAMECLQKADRRSLLSEIQALHAQMNGRKITLKREQESEKPSQELLEYNIQQKQSQMLEMQVELSSMKDRATELQEQLSSEKMVVAELKSELAQTKLELETTLKAQHKHLKELEAFRLEVKDKTDEVHLLNDTLASEQKKSRELQWALEKEKAKLGRSEERDKEELEDLKFSLESQKQRNLQLNLLLEQQKQLLNESQQKIESQRMLYDAQLSEEQGRNLELQVLLESEKVRIREMSSTLDRERELHAQLQSSDGTGQSRPPLPSEDLLKELQKQLEEKHSRIVELLNETEKYKLDSLQTRQQMEKDRQVHRKTLQTEQEANTEGQKKMHELQSKVEDLQRQLEEKRQQVYKLDLEGQRLQGIMQEFQKQELEREEKRESRRILYQNLNEPTTWSLTSDRTRNWVLQQKIEGETKESNYAKLIEMNGGGTGCNHELEMIRQKLQCVASKLQVLPQKASERLQFETADDEDFIWVQENIDEIILQLQKLTGQQGEEPSLVSPSTSCGSLTERLLRQNAELTGHISQLTEEKNDLRNMVMKLEEQIRWYRQTGAGRDNSSRFSLNGGANIEAIIASEKEVWNREKLTLQKSLKRAEAEVYKLKAELRNDSLLQTLSPDSEHVTLKRIYGKYLRAESFRKALIYQKKYLLLLLGGFQECEDATLALLARMGGQPAFTDLEVITNRPKGFTRFRSAVRVSIAISRMKFLVRRWHRVTGSVSININRDGFGLNQGAEKTDSFYHSSGGLELYGEPRHTTYRSRSDLDYIRSPLPFQNRYPGTPADFNPGSLACSQLQNYDPDRALTDYITRLEALQRRLGTIQSGSTTQFHAGMRR
Q16875O43622O75902F263_HUMAN6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 36PF-2-K/Fru-2,6-P2ASE brain/placenta-type isozymeiPFK-2Renal carcinoma antigen NY-REN-566-phosphofructo-2-kinaseFructose-2,6-bisphosphatasePFKFB3Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCloning of cDNA encoding for a novel isozyme of fructose 6-phosphate, 2-kinase/fructose 2,6-bisphosphatase from human placenta.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)PlacentaMolecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase gene (PFKFB3).NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)BrainHuman brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)BrainAn inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)Skeletal muscleThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)TestisAntigens recognized by autologous antibody in patients with renal-cell carcinoma.IDENTIFICATION AS A RENAL CANCER ANTIGENRenal cell carcinomaSynthesis and degradation of fructose 2,6-bisphosphate.Beta-D-fructose 2,6-bisphosphate + H(2)O = D-fructose 6-phosphate + phosphate.ATP + D-fructose 6-phosphate = ADP + beta-D-fructose 2,6-bisphosphate.false1Q13617false1Q16875-11Q16875-22Ubiquitous.In the C-terminal section; belongs to the phosphoglycerate mutase family.3D-structureAlternative splicingATP-bindingHydrolaseKinaseMultifunctional enzymeNucleotide-bindingPhosphoproteinTransferaseNMKGSRSSADSSRKHPLLGQACLTMVAG
MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH
P35348O60451Q13675Q13729Q6RUJ4Q6RUJ5Q6RUJ7Q6RUJ8Q6RUJ9Q9UD63ADA1A_HUMANAlpha-1A adrenergic receptorAlpha 1A-adrenoceptorAlpha 1A-adrenoreceptorAlpha-1C adrenergic receptorAlpha-adrenergic receptor 1cADRA1AADRA1CHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor.NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)VARIANT ARG-347ProstateCloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c.NUCLEOTIDE SEQUENCE (ISOFORM 1)VARIANT ARG-347HeartThe alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)HippocampusLymphocyteThe alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)VARIANT ARG-347Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)VARIANT ARG-347Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3)VARIANT ARG-347TISSUE SPECIFICITYProstateMolecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)TISSUE SPECIFICITYProstateTruncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors.NUCLEOTIDE SEQUENCE (ISOFORMS 2B/3B; 2C; 3C; 5 AND 6)LiverGenome-wide discovery and analysis of human seven transmembrane helix receptor genes.NUCLEOTIDE SEQUENCE (ISOFORM 1)cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy.VARIANT ARG-347Alpha 1A-adrenergic receptor polymorphism and vascular response.VARIANT ARG-347The consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] TRP-40This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins.Cell membrane; Multi-pass membrane protein.P35348-11Alpha 1c-1,Alpha(1A-1)P35348-22Alpha 1c-2,Alpha(1A-2)P35348-33Alpha 1c-3,Alpha(1A-3)P35348-44Alpha(1A-4)P35348-55P35348-66P35348-72b/3bP35348-82cP35348-93cHeart, brain, liver and prostate, but not in kidney, lung, adrenal, aorta and pituitary. Isoform 4 is the most abundant isoform expressed in the prostate with high levels also detected in liver and heart.Carboxyl-terminal Ser or Thr residues may be phosphorylated.Belongs to the G-protein coupled receptor 1 family.Alternative splicingG-protein coupled receptorGlycoproteinLipoproteinMembranePalmitatePhosphoproteinPolymorphismReceptorTransducerTransmembraneGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEVDEVSLCHQAGVQWHDLGSLQPPPPGFKRF SCLSLPSSWDYRDVPPGRRHQAQLIFVFLVETGFHHVGQDD LDLLTSGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRDEETEAQQGKNDSPSFKQPVHHAAVLGLEV MEKENLEGVSRKDTCGVWSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEVTHTHDMKPASRPRLLSLLPKEGEHETHHWS CDPLSLESTPGAQEPCLTLGFTSLSSIHLTKAQIQHVTVTD TGKTVTSFFPDFKPSETVFKIVFWLGYLNSCINPITYILKYDV LFWRKGLSVCTRLRERKEIKNSFKSVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEVTKSRSVTRLECSGMILAHCNLRLPGSRDSPASASQ AAGTTGDVPPGRRHQAQLIFVFLVETGFHHVGQDDLDLLTSVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEVRGMDCRYFTKNCREHIKHVNFMMPPWRKGLECVRSKSFGHTPMTGWCRGCSTQCTPQESC
MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV
Q8N8S7Q502W5Q5T5M7Q5VTQ9Q5VTR0Q9NVF3Q9UFB8ENAH_HUMANProtein enabled homologENAHMENAHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoHuman Mena: cDNA cloning, expression and promoter characterization.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)TISSUE SPECIFICITYMammary tumorThe DNA sequence and biological annotation of human chromosome 1.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 44-591 (ISOFORM 2)PlacentaSkinComplete sequencing and characterization of 21,243 full-length human cDNAs.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 85-591 (ISOFORM 2)TeratocarcinomaNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 393-591 (ISOFORM 2)TestisCdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex.PROTEIN SEQUENCE OF 23-47; 70-81; 123-145; 403-427; 484-499 AND 573-587FUNCTIONINTERACTION WITH BAIAP2A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family.INTERACTION WITH VCL; ZYX AND L.MONOCYTOGENES ACTACharacterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins.INTERACTION WITH ZYXRobo4 is a vascular-specific receptor that inhibits endothelial migration.INTERACTION WITH ROBO4RIAM, an Ena/VASP and profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion.INTERACTION WITH APBB1IPT-cellLamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics.SUBCELLULAR LOCATIONGlobal, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-508MASS SPECTROMETRYEpitheliumA probability-based approach for high-throughput protein phosphorylation analysis and site localization.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-489MASS SPECTROMETRYEpitheliumGlobal proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-405; THR-410; THR-502 AND SER-508MASS SPECTROMETRYATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125MASS SPECTROMETRYEna/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts syngeristically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation. Required for the actin-based mobility of Listeria monocytogenes.Homotetramer (By similarity). Interacts with APBB1IP, PFN1 and ROBO4. Isoforms, containing the polyproline-rich regions with PPLP motifs, bind the WW domain of APBB1IP. Isoforms, containing the PPSY motif, bind, in vitro, to the WW2 and WW3 domains of NEDD4 and to the WW1 domain of YAP1. Binds the SH3 domain of BAIAP2-alpha but only after the autoinhibitory region of BAIAP2-alpha has been blocked by interaction with CDC42. Interacts, via the EVH1/WH1 domain, with the Pro-rich domains from VCL, ZYX and Listeria monocytogenes actA. Interaction with ZYX is important for targeting ENAH to focal adhesions and enhances production of actin-rich structures at the apical surface of cells. Interacts, through the Pro-rich region, with the C-terminal SH3 domain of DNMPB. Binds GPHN.Cytoplasm. Cytoplasm, cytoskeleton (By similarity). Cell projection, lamellipodium (By similarity). Cell projection, filopodium (By similarity). Cell junction, synapse (By similarity). Note=Targeted to the leading edge of lamellipodia and filopodia by MRL family members. Colocalizes at filopodial tips with a number of other proteins including vinculin and zyxlin. Colocalizes with N-WASP at the leading edge. Colocalizes with GPHN and PFN at synapses.Q8N8S7-11Q8N8S7-22Expressed in myoepithelia of parotid, breast, bronchial glands and sweat glands. Expressed in colon-rectum muscolaris mucosae epithelium, pancreas acinar ductal epithelium, endometrium epithelium, prostate fibromuscolar stroma and placenta vascular media. Overexpressed in a majority of breast cancer cell lines and primary breast tumor lesions.The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization.NTN1-induced PKA phosphorylation on Ser-265 directly parallels the formation of filopodial protrusions.Phosphorylated upon DNA damage, probably by ATM or ATR.Belongs to the Ena/VASP family.Contains 1 WH1 domain.Actin-bindingAlternative splicingCell junctionCell projectionCoiled coilCytoplasmCytoskeletonDirect protein sequencingPhosphoproteinRepeatSH3-bindingSynapseTI
MSEQSICQARAAVMVYDDANKKWVPAGGSTGFSRVHIYHHTGNNTFRVVGRKIQDHQVVINCAIPKGLKYNQATQTFHQWRDARQVYGLNFGSKEDANVFASAMMHALEVLNSQETGPTLPRQNSQLPAQVQNGPSQEELEIQRRQLQEQQRQKELERERLERERMERERLERERLERERLERERLEQEQLERERQERERQERLERQERLERQERLERQERLDRERQERQERERLERLERERQERERQEQLEREQLEWERERRISSAAAPASVETPLNSVLGDSSASEPGLQAASQPAETPSQQGIVLGPLAPPPPPPLPPGPAQASVALPPPPGPPPPPPLPSTGPPPPPPPPPLPNQVPPPPPPPPAPPLPASGFFLASMSEDNRPLTGLAAAIAGAKLRKVSRMEDTSFPSGGNAIGVNSASSKTDTGRGNGPLPLGGSGLMEEMSALLARRRRIAEKGSTIETEQKEDKGEDSEPVTSKASSTSTPEPTRKPWERTNTMNGSKSPVISRRDSPRKNQIVFDNRSYDSLHRPKSTPLSQPSANGVQTEGLDYDRLKQDILDEMRKELTKLKEELIDAIRQELSKSNTA
Q15506Q9BXF7SP17_HUMANSperm surface protein Sp17Sperm autoantigenic protein 17Sperm protein 17Sp17-1Cancer/testis antigen 22CT22SPA17SP17Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCloning and sequencing of cDNAs encoding the human sperm protein, Sp17.NUCLEOTIDE SEQUENCE [MRNA]TestisGenomic organization of an intron-containing sperm protein 17 gene (Sp17-1) and an intronless pseudogene (Sp17-2) in humans: a new model.NUCLEOTIDE SEQUENCE [MRNA]TestisThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]BrainA yeast two-hybrid system using Sp17 identified ropporin as a novel cancer-testis antigen in hematologic malignancies.POSSIBLE INTERACTION WITH ROPN1Sperm surface zona pellucida binding protein. Helps to bind spermatozoa to the zona pellucida with high affinity. Might function in binding zona pellucida and carbohydrates.Homodimer (By similarity). May interact with ROPN1.Membrane; Peripheral membrane protein .Testis and sperm specific.Contains 1 IQ domain.Membrane
MSIPFSNTHYRIPQGFGNLLEGLTREILREQPDNIPAFAAAYFESLLEKREKTNFDPAEWGSKVEDRFYNNHAFEEQEPPEKSDPKQEESQISGKEEETSVTILDSSEEDKEKEEVAAVKIQAAFRGHIAREEAKKMKTNSLQNEEKEENK
P35228O60757O94994Q16263Q16692Q4TTS5NOS2A_HUMANNitric oxide synthase, inducibleNOS type IIInducible NO synthaseInducible NOSiNOSHepatocyte NOSHEP-NOSNOS2ANOS2Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoMolecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.NUCLEOTIDE SEQUENCE [MRNA]LiverPurification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line.NUCLEOTIDE SEQUENCE [MRNA]Colon adenocarcinomaCloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte.NUCLEOTIDE SEQUENCE [MRNA]ChondrocyteInducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression.NUCLEOTIDE SEQUENCE [MRNA]Articular chondrocyteHuman retina expresses both constitutive and inducible isoforms of nitric oxide synthase mRNA.NUCLEOTIDE SEQUENCE [MRNA]VARIANT LEU-608RetinaCloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172.NUCLEOTIDE SEQUENCE [MRNA]VARIANT LEU-608GlioblastomaContinuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.NUCLEOTIDE SEQUENCE [MRNA]Airway epitheliumDedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS.NUCLEOTIDE SEQUENCE [MRNA]Cardiac myocyteCloning and characterization of a novel splice valiant of human inducible nitric oxide synthase.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).NUCLEOTIDE SEQUENCE [GENOMIC DNA]VARIANTS TRP-221; LEU-608; ALA-747 AND CYS-1009Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism?NUCLEOTIDE SEQUENCE [MRNA] OF 380-473KidneyThree members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17.CHARACTERIZATIONInducible nitric oxide synthase in the liver: regulation and function.CHARACTERIZATIONEpithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output.INTERACTION WITH SLC9A3R1Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase.X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 74-504Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 82-528The consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] SER-679Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In macrophages, NO mediates tumoricidal and bactericidal actions.L-arginine + n NADPH + m O(2) = citrulline + nitric oxide + n NADP(+).Heme group.Binds 1 FAD.Binds 1 FMN.Metrahydrobiopterin (BH4). May stabilize the dimeric form of the enzyme.Regulated by calcium/calmodulin. Aspirin inhibits expression and function of this enzyme and effects may be exerted at the level of translational/post-translational modification and directly on the catalytic activity.Homodimer. Binds SLC9A3R1.P35228-11P35228-22Expressed in the liver, retina, bone cells and airway epithelial cells of the lung. Not expressed in the platelets.By endotoxins and cytokines.Belongs to the NOS family.Contains 1 flavodoxin-like domain.Nitric oxide synthase entry3D-structureAlternative splicingCalciumCalmodulin-bindingFADFMNHemeIronMetal-bindingNADPOxidoreductasePhosphoproteinPolymorphismZincRWSLASTARCDGFLGVRHLIATTITAADFLSPSPRGGAAV
MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLSKQQNESPQPLVETGKKSPESLVKLDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQDEKRRPKRREIPLKVLVKAVLFACMLMRKTMASRVRVTILFATETGKSEALAWDLGALFSCAFNPKVVCMDKYRLSCLEEERLLLVVTSTFGNGDCPGNGEKLKKSLFMLKELNNKFRYAVFGLGSSMYPRFCAFAHDIDQKLSHLGASQLTPMGEGDELSGQEDAFRSWAVQTFKAACETFDVRGKQHIQIPKLYTSNVTWDPHHYRLVQDSQPLDLSKALSSMHAKNVFTMRLKSRQNLQSPTSSRATILVELSCEDGQGLNYLPGEHLGVCPGNQPALVQGILERVVDGPTPHQTVRLEALDESGSYWVSDKRLPPCSLSQALTYFLDITTPPTQLLLQKLAQVATEEPERQRLEALCQPSEYSKWKFTNSPTFLEVLEEFPSLRVSAGFLLSQLPILKPRFYSISSSRDHTPTEIHLTVAVVTYHTRDGQGPLHHGVCSTWLNSLKPQDPVPCFVRNASGFHLPEDPSHPCILIGPGTGIAPFRSFWQQRLHDSQHKGVRGGRMTLVFGCRRPDEDHIYQEEMLEMAQKGVLHAVHTAYSRLPGKPKVYVQDILRQQLASEVLRVLHKEPGHLYVCGDVRMARDVAHTLKQLVAAKLKLNEEQVEDYFFQLKSQKRYHEDIFGAVFPYEAKKDRVAVQPSSLEMSAL
Q13023O15028AKAP6_HUMANA-kinase anchor protein 6Protein kinase A-anchoring protein 6PRKA6A-kinase anchor protein 100 kDaAKAP 100mAKAPAKAP6AKAP100KIAA0311Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomomAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes.NUCLEOTIDE SEQUENCE [MRNA]VARIANT VAL-1492Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]BrainConstruction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.SEQUENCE REVISIONCloning and characterization of A-kinase anchor protein 100 (AKAP100). A protein that targets A-kinase to the sarcoplasmic reticulum.NUCLEOTIDE SEQUENCE [MRNA] OF 1666-2319HippocampusThe consensus coding sequences of human breast and colorectal cancers.VARIANTS [LARGE SCALE ANALYSIS] MET-910; ILE-1192; GLN-1702 AND THR-1839Binds to type II regulatory subunits of protein kinase A and anchors/targets them to the nuclear membrane or sarcoplasmic reticulum. May act as an adapter for assembling multiprotein complexes.Interacts with RII subunit of PKA, phosphatase 2B (calcineurin) and AKAP79.Sarcoplasmic reticulum. Nucleus membrane. Note=In heart muscle. Participation of multiple targeting signals allow correct intracellular targeting. These may be repeated motifs rich in basic and hydrophobic amino acids, palmitoylated/myristoylated motifs or alternatively splice targeting sequences.Highly expressed in cardiac and skeletal muscle, followed by brain.RII-alpha binding site, predicted to form an amphipathic helix, could participate in protein-protein interactions with a complementary surface on the R-subunit dimer.Contains 2 spectrin repeats.MembraneNucleusPolymorphismRepeatSarcoplasmic reticulumAVNSKMMIAVEQPTNDFYDHWC
MLTMSVTLSPLRSQDLDPMATDASPMAINMTPTVEQGEGEEAMKDMDSDQQYEKPPPLHTGADWKIVLHLPEIETWLRMTSERVRDLTYSVQQDSDSKHVDVHLVQLKDICEDISDHVEQIHALLETEFSLKLLSYSVNVIVDIHAVQLLWHQLRVSVLVLRERILQGLQDANGNYTRQTDILQAFSEETKEGRLDSLTEVDDSGQLTIKCSQNYLSLDCGITAFELSDYSPSEDLLSGLGDMTSSQVKTKPFDSWSYSEMEKEFPELIRSVGLLTVAADSISTNGSEAVTEEVSQVSLSVDDKGGCEEDNASAVEEQPGLTLGVSSSSGEALTNAAQPSSETVQQESSSSSHHDAKNQQPVPCENATPKRTIRDCFNYNEDSPTQPTLPKRGLFLKEETFKNDLKGNGGKRQMVDLKPEMSRSTPSLVDPPDRSKLCLVLQSSYPNSPSAASQSYECLHKVGNGNLENTVKFHIKEISSSLGRLNDCYKEKSRLKKPHKTSEEVPPCRTPKRGTGSGKQAKNTKSSAVPNGELSYTSKAIEGPQTNSASTSSLEPCNQRSWNAKLQLQSETSSSPAFTQSSESSVGSDNIMSPVPLLSKHKSKKGQASSPSHVTRNGEVVEAWYGSDEYLALPSHLKQTEVLALKLENLTKLLPQKPRGETIQNIDDWELSEMNSDSEIYPTYHVKKKHTRLGRVSPSSSSDIASSLGESIESGPLSDILSDEESSMPLAGMKKYADEKSERASSSEKNESHSATKSALIQKLMQDIQHQDNYEAIWEKIEGFVNKLDEFIQWLNEAMETTENWTPPKAEMDDLKLYLETHLSFKLNVDSHCALKEAVEEEGHQLLELIASHKAGLKDMLRMIASQWKELQRQIKRQHSWILRALDTIKAEILATDVSVEDEEGTGSPKAEVQLCYLEAQRDAVEQMSLKLYSEQYTSSSKRKEEFADMSKVHSVGSNGLLDFDSEYQELWDWLIDMESLVMDSHDLMMSEEQQQHLYKRYSVEMSIRHLKKTELLSKVEALKKGGVLLPNDLLEKVDSINEKWELLGKTLGEKIQDTMAGHSGSSPRDLLSPESGSLVRQLEVRIKELKGWLRDTELFIFNSCLRQEKEGTMNTEKQLQYFKSLCREIKQRRRGVASILRLCQHLLDDRETCNLNADHQPMQLIIVNLERRWEAIVMQAVQWQTRLQKKMGKESETLNVIDPGLMDLNGMSEDALEWDEMDISNKLISLNEESNDLDQELQPVIPSLKLGETSNEDPGYDEEADNHGGSQYASNITAPSSPHIYQVYSLHNVELYEDNHMPFLKNNPKVTGMTQPNVLTKSLSKDSSFSSTKSLPDLLGGSNLVKPCACHGGDMSQNSGSESGIVSEGDTETTTNSEMCLLNAVDGSPSNLETEHLDPQMGDAVNVLKQKFTDEGESIKLPNSSQSSISPVGCVNGKVGDLNSITKHTPDCLGEELQGKHDVFTFYDYSYLQGSKLKLPMIMKQSQSEKAHVEDPLLRGFYFDKKSCKSKHQTTELQPDVPPHERILASASHEMDRISYKSGNIEKTFTGMQNAKQLSLLSHSSSIESLSPGGDLFGLGIFKNGSDSLQRSTSLESWLTSYKSNEDLFSCHSSGDISVSSGSVGELSKRTLDLLNRLENIQSPSEQKIKRSVSDITLQSSSQKMSFTGQMSLDIASSINEDSAASLTELSSSDELSLCSEDIVLHKNKIPESNASFRKRLTRSVADESDVNVSMIVNVSCTSACTDDEDDSDLLSSSTLTLTEEELCIKDEDDDSSIATDDEIYEDCTLMSGLDYIKNELQTWIRPKLSLTRDKKRCNVSDEMKGSKDISSSEMTNPSDTLNIETLLNGSVKRVSENNGNGKNSSHTHELGTKRENKKTIFKVNKDPYVADMENGNIEGIPERQKGKPNVTSKVSENLGSHGKEISESEHCKCKALMDSLDDSNTAGKEFVSQDVRHLPKKCPNHHHFENQSTASTPTEKSFSELALETRFNNRQDSDALKSSDDAPSMAGKSAGCCLALEQNGTEENASISNISCCNCEPDVFHQKDAEDCSVHNFVKEIIDMASTALKSKSQPENEVAAPTSLTQIKEKVLEHSHRPIQLRKGDFYSYLSLSSHDSDCGEVTNYIEEKSSTPLPLDTTDSGLDDKEDIECFFEACVEGDSDGEEPCFSSAPPNESAVPSEAAMPLQATACSSEFSDSSLSADDADTVALSSPSSQERAEVGKEVNGLPQTSSGCAENLEFTPSKLDSEKESSGKPGESGMPEEHNAASAKSKVQDLSLKANQPTDKAALHPSPKTLTCEENLLNLHEKRHRNMHR
Q9UI08O95884Q7Z522Q8TBV1Q9UF25Q9UIC2EVL_HUMANEna/VASP-like proteinEna/vasodilator-stimulated phosphoprotein-likeEVLRNB6Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoNUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)Cloning of a new human cDNA homologous to R.norvegicus RNB6 mRNA.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)Adrenal glandThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)LungPancreasNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 55-416BrainNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 163-364UterusThe orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain.INTERACTION WITH SEMA6ALamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics.INTERACTION WITH RAPH1Large-scale characterization of HeLa cell nuclear phosphoproteins.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329 AND SER-331MASS SPECTROMETRYEpitheliumImproved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS Spectra.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-250MASS SPECTROMETRYEpitheliumThe consensus coding sequences of human breast and colorectal cancers.VARIANTS [LARGE SCALE ANALYSIS] LEU-188 AND LEU-247Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. EVL enhances actin nucleation and polymerization. Required to transform actin polymerization into active movement for the propulsive force of Listeria monocytogenes.Homotetramer (By similarity). Binds to the SH3 domains of ABL1, LYN and SRC. Also binds to profilin, with preference for isoform IIa of PFN2, and the WW domain of APBB1/FE65. Binds to SEMA6A. Interacts, via the Pro-rich region, with the C-terminal SH3 domain of DNMBP. Interacts with RAPH1. Binds, via the EVH1 domain, the Pro-rich domain of Listeria monocytogenes actA.P08631false1Cytoplasm, cytoskeleton (By similarity). Cell projection, lamellipodium (By similarity). Note=Targeted to the leading edge of lamellipodia and the dital tip of stress fibers through interaction with a number of proteins. In activated T-cells, localizes to the F-actin collar and the distal tip of microspikes.Q9UI08-12Q9UI08-21The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization.Phosphorylated by PKA; phosphorylation abolishes binding to SH3 domains of ABL and SRC.Belongs to the Ena/VASP family.Contains 1 WH1 domain.Actin-bindingAlternative splicingCell projectionCytoplasmCytoskeletonPhosphoproteinPolymorphismSH3-bindingMMATPLPLPSSNMY
MSEQSICQARASVMVYDDTSKKWVPIKPGQQGFSRINIYHNTASNTFRVVGVKLQDQQVVINYSIVKGLKYNQATPTFHQWRDARQVYGLNFASKEEATTFSNAMLFALNIMNSQEGGPSSQRQVQNGPSPDEMDIQRRQVMEQHQQQRQESLERRTSATGPILPPGHPSSAASAPVSCSGPPPPPPPPVPPPPTGATPPPPPPLPAGGAQGSSHDESSMSGLAAAIAGAKLRRVQRPEDASGGSSPSGTSKSDANRASSGGGGGGLMEEMNKLLAKRRKAASQSDKPAEKKEDESQMEDPSTSPSPGTRAASQPPNSSEAGRKPWERSNSVEKPVSSILSRTPSVAKSPEAKSPLQSQPHSRMKPAGSVNDMALDAFDLDRMKQEILEEVVRELHKVKEEIIDAIRQELSGISTT
P08670Q15867Q15868Q15869Q6LER9Q8N850Q96ML2Q9NTM3VIME_HUMANVimentinVIMHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCoding sequence and growth regulation of the human vimentin gene.NUCLEOTIDE SEQUENCE [GENOMIC DNA]Nucleotide sequence of cDNA covering the complete coding part of the human vimentin gene.NUCLEOTIDE SEQUENCE [MRNA]NUCLEOTIDE SEQUENCEComplete sequencing and characterization of 21,243 full-length human cDNAs.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]PlacentaStomachCloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]The DNA sequence and comparative analysis of human chromosome 10.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]CervixPlacentaTestisVimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells.NUCLEOTIDE SEQUENCE OF 1-135TISSUE SPECIFICITYMammary carcinomaPROTEIN SEQUENCE OF 2-11; 87-96; 129-138; 188-195; 223-234; 282-291; 322-333 AND 381-389CLEAVAGE OF INITIATOR METHIONINEACETYLATION AT SER-2MASS SPECTROMETRYT-cellTwo-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2.PROTEIN SEQUENCE OF 17-25 AND 55-70Mammary carcinomaPROTEIN SEQUENCE OF 79-97 AND 411-424MASS SPECTROMETRYBrainCajal-Retzius cellNucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells.NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 113-466TISSUE SPECIFICITYFibroblastIsolation of a human vimentin cDNA with a long 3'-noncoding region from a human osteosarcoma cell line (MG-63).NUCLEOTIDE SEQUENCE [MRNA] OF 167-466OsteosarcomaSpecific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments.PHOSPHORYLATION AT SER-5; SER-7; SER-8; SER-9; SER-10; SER-39; SER-42; SER-72; SER-73; SER-420; SER-430; THR-458 AND SER-459MASS SPECTROMETRYImmunoaffinity profiling of tyrosine phosphorylation in cancer cells.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-117MASS SPECTROMETRYProteomic profiling of cellular proteins interacting with the hepatitis C virus core protein.INTERACTION WITH HCV CORE PROTEINMEGF10 is a mammalian ortholog of CED-1 that interacts with clathrin assembly protein complex 2 medium chain and induces large vacuole formation.IDENTIFICATION IN A COMPLEX WITH ACTB; AP2M1; AP2A1; AP2A2 AND MEGF10Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-56; SER-73; SER-214 AND SER-412MASS SPECTROMETRYEpitheliumA probability-based approach for high-throughput protein phosphorylation analysis and site localization.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56MASS SPECTROMETRYEpitheliumPhosphoproteome analysis of the human mitotic spindle.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56MASS SPECTROMETRYEpitheliumImproved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS Spectra.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56; SER-412; THR-446 AND SER-459MASS SPECTROMETRYEpitheliumGlobal proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-47; SER-55; SER-56; TYR-61; SER-430; THR-458 AND SER-459MASS SPECTROMETRYDivide-and-conquer crystallographic approach towards an atomic structure of intermediate filaments.X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 102-138Conserved segments 1A and 2B of the intermediate filament dimer: their atomic structures and role in filament assembly.X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 103-139 AND 328-411Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells.Homopolymer. Component of a complex composed at least of ACTB, AP2M1, AP2A1, AP2A2, MEGF10 and VIM. Interacts with HCV core protein.Q14194false1Q00987false1O95251false2Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines.One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized.Belongs to the intermediate filament family.Vimentin entryIntron retention.3D-structureAcetylationCoiled coilDirect protein sequencingHost-virus interactionIntermediate filamentPhosphoproteinSDRPEGNSLSSISCNKLF
MSTRSVSSSSYRRMFGGPGTASRPSSSRSYVTTSTRTYSLGSALRPSTSRSLYASSPGGVYATRSSAVRLRSSVPGVRLLQDSVDFSLADAINTEFKNTRTNEKVELQELNDRFANYIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVRQQYESVAAKNLQEAEEWYKSKFADLSEAANRNNDALRQAKQESTEYRRQVQSLTCEVDALKGTNESLERQMREMEENFAVEAANYQDTIGRLQDEIQNMKEEMARHLREYQDLLNVKMALDIEIATYRKLLEGEESRISLPLPNFSSLNLRETNLDSLPLVDTHSKRTLLIKTVETRDGQVINETSQHHDDLE
P09917Q5JQ14LOX5_HUMANArachidonate 5-lipoxygenase5-lipoxygenase5-LOALOX5LOG5Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCloning of the cDNA for human 5-lipoxygenase.NUCLEOTIDE SEQUENCE [MRNA]PARTIAL PROTEIN SEQUENCEMolecular cloning and amino acid sequence of human 5-lipoxygenase.NUCLEOTIDE SEQUENCE [MRNA]ERRATUMMolecular cloning and amino acid sequence of human 5-lipoxygenase.NUCLEOTIDE SEQUENCEPARTIAL PROTEIN SEQUENCEThe DNA sequence and comparative analysis of human chromosome 10.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]BrainCharacterization of the human 5-lipoxygenase gene.NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-50Characterization of the human 5-lipoxygenase gene promoter.NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenase.SUBCELLULAR LOCATIONEvaluation of the role of conserved His and Met residues among lipoxygenases by site-directed mutagenesis of recombinant human 5-lipoxygenase.MUTAGENESIS OF SOME HISTIDINE RESIDUESMutagenesis studies on the amino acid residues involved in the iron-binding and the activity of human 5-lipoxygenase.MUTAGENESIS OF SOME RESIDUESArachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2).PHOSPHORYLATION AT SER-272Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523.PHOSPHORYLATION AT SER-524MUTAGENESIS OF SER-524Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk.VARIANT LYS-254Arachidonate + O(2) = (6E,8Z,11Z,14Z)-(5S)-5-hydroperoxyicosa-6,8,11,14-tetraenoate.(6E,8Z,11Z,14Z)-(5S)-5-hydroperoxyicosa-6,8,11,14-tetraenoate = (7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa-7,9,11,14-tetraenoate + H(2)O.Binds 1 iron ion per subunit.Binds 2 calcium ions per subunit.Leukotrienes biosynthesis; first step.Leukotrienes biosynthesis; second step.Q14019false3Cytoplasm; Peripheral membrane protein. Note=Calcium binding promotes binding to membranes.Serine phosphorylation of LOX5 by MAPKAPK2 is stimulated by arachidonic acid. Serine phosphorylation of LOX5 on Ser-523 by PKA has an inhibitory effect.Belongs to the lipoxygenase family.Contains 1 PLAT domain.3D-structureCalciumCytoplasmDioxygenaseDirect protein sequencingIronLeukotriene biosynthesisMembraneMetal-bindingOxidoreductasePhosphoproteinPolymorphismEKDNHSNHSNAHSNEQHAHSNHAHSNHNASAHNA
MPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGAVDSYDVTVDEELGEIQLVRIEKRKYWLNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGCNPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWCSWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNKKKQLPYYYLSPDRIPNSVAI
P22102O14659PUR2_HUMANTrifunctional purine biosynthetic protein adenosine-3Phosphoribosylamine--glycine ligaseGARSGlycinamide ribonucleotide synthetasePhosphoribosylglycinamide synthetasePhosphoribosylformylglycinamidine cyclo-ligaseAIRSPhosphoribosyl-aminoimidazole synthetaseAIR synthasePhosphoribosylglycinamide formyltransferaseGARTGAR transformylase5'-phosphoribosylglycinamide transformylaseGARTPGFTPRGSHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoDe novo purine nucleotide biosynthesis: cloning of human and avian cDNAs encoding the trifunctional glycinamide ribonucleotide synthetase-aminoimidazole ribonucleotide synthetase-glycinamide ribonucleotide transformylase by functional complementation in E. coli.NUCLEOTIDE SEQUENCE [MRNA]ALTERNATIVE SPLICINGThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT)TestisIntronic polyadenylation in the human glycinamide ribonucleotide formyltransferase gene.NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 357-432VARIANT ILE-421Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations.NUCLEOTIDE SEQUENCE [MRNA] OF 709-1010Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-348MASS SPECTROMETRYCrystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 808-1010 IN COMPLEX WITH SUBSTRATERational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 808-1010 IN COMPLEX WITH FORMYLTETRAHYDROFOLATE ANALOGThe apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase.X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 808-1010 IN COMPLEX WITH SUBSTRATE ANALOGSATP + 5-phospho-D-ribosylamine + glycine = ADP + phosphate + N(1)-(5-phospho-D-ribosyl)glycinamide.ATP + 2-(formamido)-N(1)-(5-phospho-D-ribosyl)acetamidine = ADP + phosphate + 5-amino-1-(5-phospho-D-ribosyl)imidazole.10-formyltetrahydrofolate + N(1)-(5-phospho-D-ribosyl)glycinamide = tetrahydrofolate + N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide.Nucleotide biosynthesis; IMP biosynthesis; N(1)-(5-phospho-D-ribosyl)glycinamide from 5-phospho-alpha-D-ribose 1-diphosphate: step 2/2.Nucleotide biosynthesis; IMP biosynthesis; 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide: step 2/5.Nucleotide biosynthesis; IMP biosynthesis; N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide from N(1)-(5-phospho-D-ribosyl)glycinamide (10-formyl THF route): step 1/1.Context: Purine biosynthesis.P62330false1P22102-1LongP22102-2ShortIn the N-terminal section; belongs to the GARS family.In the central section; belongs to the AIR synthase family.In the C-terminal section; belongs to the GART family.Contains 1 ATP-grasp domain.3D-structureAlternative splicingATP-bindingLigaseMultifunctional enzymeNucleotide-bindingPhosphoproteinPolymorphismPurine biosynthesisTransferaseLFVIDG
MAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGNLRSAGVQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKAFGAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQEGTPYTGILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEITGFPEAQALGLEVFHAGTALKNGKVVTHGGRVLAVTAIRENLISALEEAKKGLAAIKFEGAIYRKDVGFRAIAFLQQPRSLTYKESGVDIAAGNMLVKKIQPLAKATSRSGCKVDLGGFAGLFDLKAAGFKDPLLASGTDGVGTKLKIAQLCNKHDTIGQDLVAMCVNDILAQGAEPLFFLDYFSCGKLDLSVTEAVVAGIAKACGKAGCALLGGETAEMPDMYPPGEYDLAGFAVGAMERDQKLPHLERITEGDVVVGIASSGLHSNGFSLVRKIVAKSSLQYSSPAPDGCGDQTLGDLLLTPTRIYSHSLLPVLRSGHVKAFAHITGGGLLENIPRVLPEKLGVDLDAQTWRIPRVFSWLQQEGHLSEEEMARTFNCGVGAVLVVSKEQTEQILRDIQQHKEEAWVIGSVVARAEGSPRVKVKNLIESMQINGSVLKNGSLTNHFSFEKKKARVAVLISGTGSNLQALIDSTREPNSSAQIDIVISNKAAVAGLDKAERAGIPTRVINHKLYKNRVEFDSAIDLVLEEFSIDIVCLAGFMRILSGPFVQKWNGKMLNIHPSLLPSFKGSNAHEQALETGVTVTGCTVHFVAEDVDAGQIILQEAVPVKRGDTVATLSERVKLAEHKIFPAALQLVASGTVQLGENGKICWVKEE
P30101Q13453Q14255Q8IYF8Q9UMU7PDIA3_HUMANProtein disulfide-isomerase A3 precursorDisulfide isomerase ER-60ERp6058 kDa microsomal proteinp58ERp5758 kDa glucose-regulated proteinPDIA3ERP57ERP60GRP58Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoMolecular cloning and characterization of a cDNA for bovine phospholipase C-alpha: proposal of redesignation of phospholipase C-alpha.NUCLEOTIDE SEQUENCE [MRNA]cDNA cloning and baculovirus expression of the human liver endoplasmic reticulum P58: characterization as a protein disulfide isomerase isoform, but not as a protease or a carnitine acyltransferase.NUCLEOTIDE SEQUENCE [MRNA]LiverERp60 does not substitute for protein disulphide isomerase as the beta-subunit of prolyl 4-hydroxylase.NUCLEOTIDE SEQUENCE [MRNA]HeartCloning, expression and genomic organization of human placental protein disulfide isomerase (previously identified as phospholipase C alpha).NUCLEOTIDE SEQUENCE [MRNA]PlacentaStructures of the human gene for the protein disulfide isomerase-related polypeptide ERp60 and a processed gene and assignment of these genes to 15q15 and 1q21.NUCLEOTIDE SEQUENCE [GENOMIC DNA]Functions of characteristic Cys-Gly-His-Cys (CGHC) and Gln-Glu-Asp-Leu (QEDL) motifs of microsomal ER-60 protease.NUCLEOTIDE SEQUENCE [MRNA]PROTEIN SEQUENCE OF 25-34 AND 504-505MUTAGENESIS OF CYS-57; CYS-60; CYS-406 AND CYS-409Liver epitheliumThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]LiverLungLymphA two-dimensional gel database of human colon carcinoma proteins.PROTEIN SEQUENCE OF 25-54; 62-75 AND 95-104Colon carcinomaExploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.PROTEIN SEQUENCE OF 25-38PlateletHuman liver protein map: a reference database established by microsequencing and gel comparison.PROTEIN SEQUENCE OF 25-33LiverTwo-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2.PROTEIN SEQUENCE OF 26-42Mammary carcinomaMicrosequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes.PROTEIN SEQUENCE OF 95-104 AND 472-479KeratinocytePROTEIN SEQUENCE OF 306-329 AND 472-482MASS SPECTROMETRYBrainCajal-Retzius cellCluster analysis of an extensive human breast cancer cell line protein expression map database.MASS SPECTROMETRYMammary cancerProteomic analysis of early melanosomes: identification of novel melanosomal proteins.SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]MASS SPECTROMETRYERp27, a new non-catalytic endoplasmic reticulum-located human protein disulfide isomerase family member, interacts with ERp57.INTERACTION WITH ERP27Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]MASS SPECTROMETRYThe solution structure of the second thioredoxin domain of human protein disulfide-isomerase A3.STRUCTURE BY NMR OF 357-485Catalyzes the rearrangement of -S-S- bonds in proteins.Interacts with ERP27.Q03103true1P61823true1Q03518false3Endoplasmic reticulum lumen (By similarity). Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV. PubMed:11840567Belongs to the protein disulfide isomerase family.Contains 2 thioredoxin domains.Was originally thought to be a phosphatidylinositol-4,5-bisphosphate phosphodiesterase type I (phospholipase C-alpha).3D-structureDirect protein sequencingEndoplasmic reticulumIsomerasePolymorphismRedox-active centerRepeatSignalKRCACSCSCACSCSAGAVDYQPEGNDDGDGED
MRLRRLALFPGVALLLAAARLAAASDVLELTDDNFESRISDTGSAGLMLVEFFAPWCGHCKRLAPEYEAAATRLKGIVPLAKVDCTANTNTCNKYGVSGYPTLKIFRDGEEAGAYDGPRTADGIVSHLKKQAGPASVPLRTEEEFKKFISDKDASIVGFFDDSFSEAHSEFLKAASNLRDNYRFAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDKTVAYTEQKMTSGKIKKFIQENIFGICPHMTEDNKDLIQGKDLLIAYYDVDYEKNAKGSNYWRNRVMMVAKKFLDAGHKLNFAVASRKTFSHELSDFGLESTAGEIPVVAIRTAKGEKFVMQEEFSRDGKALERFLQDYFDGNLKRYLKSEPIPESNDGPVKVVVAENFDEIVNNENKDVLIEFYAPWCGHCKNLEPKYKELGEKLSKDPNIVIAKMDATANDVPSPYEVRGFPTIYFSPANKKLNPKKYEGGRELSDFISYLQREATNPPVIQEEKPKKKKKAQEDL
Q02952O00310O00498Q4LE68Q5SZ80Q5TGN1Q68D82Q99970AKA12_HUMANA-kinase anchor protein 12A-kinase anchor protein 250 kDaAKAP 250GravinMyasthenia gravis autoantigenAKAP12AKAP250Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoGravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)VARIANT GLN-216HeartChanges of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)VARIANT LYS-117Umbilical vein endothelial cellNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)VARIANTS GLN-216; GLY-920 AND LYS-1355TestisPreparation of a set of expression-ready clones of mammalian long cDNAs encoding large proteins by the ORF trap cloning method.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)VARIANTS GLN-216 AND ASP-1600BrainThe DNA sequence and analysis of human chromosome 6.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]VARIANT LYS-117Sequence of gravin cDNA isolated from a human umbilical vein endothelial cell library.NUCLEOTIDE SEQUENCE [MRNA] OF 43-1782VARIANT GLN-216Umbilical vein endothelial cellMolecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera.NUCLEOTIDE SEQUENCE [MRNA] OF 1478-1782Umbilical vein endothelial cellMultiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles.ALTERNATIVE SPLICINGGlobal, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219; SER-312; SER-565; SER-566; SER-568; SER-569; SER-598 AND SER-612MASS SPECTROMETRYEpitheliumGlobal proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253; SER-283; SER-286; SER-627; SER-629 AND SER-1331MASS SPECTROMETRYATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-388; SER-505; SER-732 AND SER-887MASS SPECTROMETRYThe consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] LYS-240Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC).Binds to dimeric RII-alpha regulatory subunit of PKC.Cytoplasm, cell cortex (Probable). Cytoplasm, cytoskeleton (Probable). Note=May be part of the cortical cytoskeleton.Q02952-11AlphaQ02952-22BetaQ02952-33GammaExpressed in endothelial cells, cultured fibroblasts and osteosarcoma, but not in platelets, leukocytes, monocytic cell lines or peripherical blood cells.Activated by lysophosphatidylcholine (lysoPC).Polybasic regions located between residues 266 and 557 are involved in binding PKC.Phosphorylated upon DNA damage, probably by ATM or ATR.Antibodies to the C-terminal of gravin can be produced by patients with myasthenia gravis (MG).Contains 3 AKAP domains.Alternative splicingCytoplasmCytoskeletonPhosphoproteinPolymorphismRepeatEEEVIVTEMLGTITITEMEKKQEKEGVIRLEKEDEDTPEINRNTIEGGRSGEGASATEEEVMQL
MGAGSSTEQRSPEQPPEGSSTPAEPEPSGGGPSAEAAPDTTADPAIAASDPATKLLQKNGQLSTINGVAEQDELSLQEGDLNGQKGALNGQGALNSQEEEEVIVTEVGQRDSEDVSERDSDKEMATKSAVVHDITDDGQEETPEIIEQIPSSESNLEELTQPTESQANDIGFKKVFKFVGFKFTVKKDKTEKPDTVQLLTVKKDEGEGAAGAGDHKDPSLGAGEAASKESEPKQSTEKPEETLKREQSHAEISPPAESGQAVEECKEEGEEKQEKEPSKSAESPTSPVTSETGSTFKKFFTQGWAGWRKKTSFRKPKEDEVEASEKKKEQEPEKVDTEEDGKAEVASEKLTASEQAHPQEPAESAHEPRLSAEYEKVELPSEEQVSGSQGPSEEKPAPLATEVFDEKIEVHQEEVVAEVHVSTVEERTEEQKTEVEETAGSVPAEELVEMDAEPQEAEPAKELVKLKETCVSGEDPTQGADLSPDEKVLSKPPEGVVSEVEMLSSQERMKVQGSPLKKLFTSTGLKKLSGKKQKGKRGGGDEESGEHTQVPADSPDSQEEQKGESSASSPEEPEEITCLEKGLAEVQQDGEAEEGATSDGEKKREGVTPWASFKKMVTPKKRVRRPSESDKEDELDKVKSATLSSTESTASEMQEEMKGSVEEPKPEEPKRKVDTSVSWEALICVGSSKKRARRGSSSDEEGGPKAMGGDHQKADEAGKDKETGTDGILAGSQEHDPGQGSSSPEQAGSPTEGEGVSTWESFKRLVTPRKKSKSKLEEKSEDSIAGSGVEHSTPDTEPGKEESWVSIKKFIPGRRKKRPDGKQEQAPVEDAGPTGANEDDSDVPAVVPLSEYDAVEREKMEAQQAQKSAEQPEQKAATEVSKELSESQVHMMAAAVADGTRAATIIEERSPSWISASVTEPLEQVEAEAALLTEEVLEREVIAEEEPPTVTEPLPENREARGDTVVSEAELTPEAVTAAETAGPLGAEEGTEASAAEETTEMVSAVSQLTDSPDTTEEATPVQEVEGGVPDIEEQERRTQEVLQAVAEKVKEESQLPGTGGPEDVLQPVQRAEAERPEEQAEASGLKKETDVVLKVDAQEAKTEPFTQGKVVGQTTPESFEKAPQVTESIESSELVTTCQAETLAGVKSQEMVMEQAIPPDSVETPTDSETDGSTPVADFDAPGTTQKDEIVEIHEENEVASGTQSGGTEAEAVPAQKERPPAPSSFVFQEETKEQSKMEDTLEHTDKEVSVETVSILSKTEGTQEADQYADEKTKDVPFFEGLEGSIDTGITVSREKVTEVALKGEGTEEAECKKDDALELQSHAKSPPSPVEREMVVQVEREKTEAEPTHVNEEKLEHETAVTVSEEVSKQLLQTVNVPIIDGAKEVSSLEGSPPPCLGQEEAVCTKIQVQSSEASFTLTAAAEEEKVLGETANILETGETLEPAGAHLVLEEKSSEKNEDFAAHPGEDAVPTGPDCQAKSTPVIVSATTKKGLSSDLEGEKTTSLKWKSDEVDEQVACQEVKVSVAIEDLEPENGILELETKSSKLVQNIIQTAVDQFVRTEETATEMLTSELQTQAHVIKADSQDAGQETEKEGEEPQASAQDETPITSAKEESESTAVGQAHSDISKDMSEASEKTMTVEVEGSTVNDQQLEEVVLPSEEEGGGAGTKSVPEDDGHALLAERIEKSLVEPKEDEKGDDVDDPENQNSALADTDASGGLTKESPDTNGPKQKEKEDAQEVELQEGKVHSESDKAITPQAQEELQKQERESAKSELTES
O75969O75945Q9UM61AKAP3_HUMANA-kinase anchor protein 3Protein kinase A-anchoring protein 3PRKA3A-kinase anchor protein 110 kDaAKAP 110Sperm oocyte-binding proteinFibrousheathin-1Fibrousheathin IFibrous sheath protein of 95 kDaFSP95Cancer/testis antigen 82CT82AKAP3AKAP110SOB1Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCloning and characterization of SOB1, a new testis-specific cDNA encoding a human sperm protein probably involved in oocyte recognition.NUCLEOTIDE SEQUENCE [MRNA]PARTIAL PROTEIN SEQUENCETestisFSP95, a testis-specific 95-kilodalton fibrous sheath antigen that undergoes tyrosine phosphorylation in capacitated human spermatozoa.NUCLEOTIDE SEQUENCE [MRNA]PARTIAL PROTEIN SEQUENCETestisIsolation and molecular characterization of AKAP110, a novel, sperm-specific protein kinase A-anchoring protein.NUCLEOTIDE SEQUENCE [MRNA]TestisIdentification of sperm-specific proteins that interact with A-kinase anchoring proteins in a manner similar to the type II regulatory subunit of PKA.INTERACTION WITH ROPN1 AND ROPN1LMUTAGENESIS OF LEU-131Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205; SER-208; SER-403; TYR-404; SER-440; SER-612; SER-635 AND SER-636MASS SPECTROMETRYSpermThe consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] CYS-831May function as a regulator of both motility- and head-associated functions such as capacitation and the acrosome reaction.Interacts with ROPN1 AND ROPN1L.Acrosome (By similarity). Note=Ribs of the fibrous sheath in the principal piece of the sperm tail. Dorsal margin of the acrosomal segment.Testis specific; only expressed in spermatids.RII-binding site, predicted to form an amphipathic helix, could participate in protein-protein interactions with a complementary surface on the R-subunit dimer.Phosphorylated on tyrosine residues.Belongs to the AKAP110 family.Direct protein sequencingPhosphoproteinPolymorphismRCLPGEEDSGKNITFSSL
MSEKVDWLQSQNGVCKVDVYSPGDNQAQDWKMDTSTDPVRVLSWLRRDLEKSTAEFQDVRFKPGESFGGETSNSGDPHKGFSVDYYNTTTKGTPERLHFEMTHKEIPCQGPRAQLGNGSSVDEVSFYANRLTNLVIAMARKEINEKIDGSENKCVYQSLYMGNEPTPTKSLSKIASELVNETVSACSRNAAPDKAPGSGDRVSGSSQSPPNLKYKSTLKIKESTKERQGPDDKPPSKKSFFYKEVFESRNGDYAREGGRFFPRERKRFRGQERPDDFTASVSEGIMTYANSVVSDMMVSIMKTLKIQVKDTTIATILLKKVLLKHAKEVVSDLIDSFLRNLHSVTGTLMTDTQFVSAVKRTVFSHGSQKATDIMDAMLRKLYNVMFAKKVPEHVRKAQDKAESYSLISMKGMGDPKNRNVNFAMKSETKLREKMYSEPKSEEETCAKTLGEHIIKEGLTLWHKSQQKECKSLGFQHAAFEAPNTQRKPASDISFEYPEDIGNLSLPPYPPEKPENFMYDSDSWAKDLIVSALLLIQYHLAQGGRRDARSFVEAAGTTNFPANEPPVAPDESCLKSAPIVGDQEQAEKKDLRSVFFNFIRNLLSETIFKRDQSPEPKVPEQPVKEDRKLCERPLASSPPRLYEDDETPGALSGLTKMAVSQIDGHMSGQMVEHLMNSVMKLCVIIAKSCDASLAELGDDKSGDASRLTSAFPDSLYECLPAKGTGSAEAVLQNAYQAIHNEMRGTSGQPPEGCAAPTVIVSNHNLTDTVQNKQLQAVLQWVAASELNVPILYFAGDDEGIQEKLLQLSAAAVDKGCSVGEVLQSVLRYEKERQLNEAVGNVTPLQLLDWLMVNL
Q9Y250Q9Y5V7Q9Y5V8Q9Y5V9Q9Y5W0Q9Y5W1Q9Y5W2LZTS1_HUMANLeucine zipper putative tumor suppressor 1F37/esophageal cancer-related gene-coding leucine-zipper motifFez1LZTS1FEZ1Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoThe FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6 AND 7)VARIANTS ESOPHAGEAL CANCER PRO-29 AND GLU-119FUNCTIONTISSUE SPECIFICITYThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)Fetal brainFunctional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.FUNCTIONALTERNATIVE SPLICINGFEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.FUNCTIONPHOSPHORYLATIONSUBCELLULAR LOCATIONINTERACTION WITH EEF1G AND CDC2Involved in the regulation of cell growth. May stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. May act as tumor suppressor.Binds EEF1G and CDC2.P30307false1Cytoplasm (By similarity). Cell membrane (By similarity). Cell projection, dendritic spine (By similarity). Cell junction, synapse, postsynaptic cell membrane, postsynaptic density (By similarity). Cell junction, synapse (By similarity). Note=Associated with the plasma membrane and with microtubules. Detected in dendritic spines, especially in the postsynaptic density.Q9Y250-11Q9Y250-22Q9Y250-33Q9Y250-44Q9Y250-55Q9Y250-66Q9Y250-77Highly expressed in testis, prostate, spleen, thymus, ovary and brain. Detected at lower levels in heart, placenta, small intestine, colon, liver, kidney, skeletal muscle and pancreas. Not detectable in primary tumors from breast and prostate and in many cancer cell lines.Phorphorylated on serine residues. Hyperphosphorylated by the cAMP-dependent kinase PKA during cell-cycle progression.Defects in LZTS1 are found in many types of tumors.Belongs to the LZTS family.Alternative splicingAnti-oncogeneCell cycleCell junctionCell projectionCoiled coilCytoplasmLipoproteinMembraneMyristatePhosphoproteinPolymorphismPostsynaptic cell membraneSynapseSSSKMGKSEDFFYIKVSQKARGAMTRCPRASSMSGSC GRRRRRRSPKELV
MGSVSSLISGHSFHSKHCRASQYKLRKSSHLKKLNRYSDGLLRFGFSQDSGHGKSSSKMGKSEDFFYIKVSQKARGSHHPDYTALSSGDLGGQAGVDFDPSTPPKLMPFSNQLEMGSEKGAVRPTAFKPVLPRSGAILHSSPESASHQLHPAPPDKPKEQELKPGLCSGALSDSGRNSMSSLPTHSTSSSYQLDPLVTPVGPTSRFGGSAHNITQGIVLQDSNMMSLKALSFSDGGSKLGHSNKADKGPSCVRSPISTDECSIQELEQKLLEREGALQKLQRSFEEKELASSLAYEERPRRCRDELEGPEPKGGNKLKQASQKSQRAQQVLHLQVLQLQQEKRQLRQELESLMKEQDLLETKLRSYEREKTSFGPALEETQWEVCQKSGEISLLKQQLKESQTEVNAKASEILGLKAQLKDTRGKLEGLELRTQDLEGALRTKGLELEVCENELQRKKNEAELLREKVNLLEQELQELRAQAALARDMGPPTFPEDVPALQRELERLRAELREERQGHDQMSSGFQHERLVWKEEKEKVIQYQKQLQQSYVAMYQRNQRLEKALQQLARGDSAGEPLEVDLEGADIPYEDIIATEI
P19838Q68D84Q86V43Q8N4X7Q9NZC0NFKB1_HUMANNuclear factor NF-kappa-B p105 subunitDNA-binding factor KBF1EBP-1Nuclear factor NF-kappa-B p50 subunitNFKB1Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoThe DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)PARTIAL PROTEIN SEQUENCECloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.NUCLEOTIDE SEQUENCE [GENOMIC DNA]Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)PARTIAL PROTEIN SEQUENCEThe complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.NUCLEOTIDE SEQUENCE [GENOMIC DNA]Genome sequencing of the chromosome 4q region implicated in human hepatocellular carcinoma pathogenesis.NUCLEOTIDE SEQUENCE [GENOMIC DNA]NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)Rectum tumorNIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).NUCLEOTIDE SEQUENCE [GENOMIC DNA]VARIANTS ILE-489; VAL-506; ILE-566; LYS-578; GLN-711 AND THR-901The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)MuscleUterusThe ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.UBIQUITINATIONA glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.PROTEOLYTIC PROCESSING OF P105GENERATION OF P50 AND P105Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.COTRANSLATIONAL FOLDING/PROCESSING OF P105GENERATION OF P50/P105NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.MUTAGENESIS OF SER-921; SER-923 AND SER-932TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.INTERACTION WITH MAP3K8Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.COTRANSLATIONAL FOLDING/PROCESSING OF P105GENERATION OF P50/P105P50/P105 TRANSIENT HETERODIMER FORMATIONRAC-3 is a NF-kappa B coactivator.INTERACTION WITH NCOA3Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappa B.INTERACTION WITH DSIPIDirect phosphorylation of NF-kappa B1 p105 by the Ikappa B kinase complex on serine 927 is essential for signal-induced p105 proteolysis.PHOSPHORYLATION AT SER-927Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.INTERACTION WITH DSIPIIdentification of a ZU5 and death domain-containing inhibitor of NF-kappaB.INTERACTION WITH UNC5CLA physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.INTERACTION WITH SPAG9Structure of the NF-kappa B p50 homodimer bound to DNA.X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-365Structure of an IkappaBalpha/NF-kappaB complex.X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 248-354Appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. Plays a role in the regulation of apoptosis.Active NF-kappa-B is a heterodimer of an about 50 kDa DNA-binding subunit and the weak DNA-binding subunit p65. Two heterodimers might form a labile tetramer. Also interacts with MAP3K8. NF-kappa-B p50 subunit interacts with NCOA3 coactivator, which may coactivate NF-kappa-B dependent expression via its histone acetyltransferase activity. Interacts with DSIPI; this interaction prevents nuclear translocation and DNA-binding. Interacts with SPAG9 and UNC5CL.Q13547false2Q14690false1O60271false1Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).P19838-11P19838-22By phorbol ester and TNF-alpha.The C-terminus of p105 might be involved in cytoplasmic retention, inhibition of DNA-binding, and transcription activation.Glycine-rich region (GRR) appears to be a critical element in the generation of p50.While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p50 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.Polyubiquitination seems to allow p105 processing.Contains 7 ANK repeats.Contains 1 death domain.Contains 1 RHD (Rel-like) domain.3D-structureActivatorAlternative splicingANK repeatApoptosisCytoplasmDirect protein sequencingDNA-bindingNucleusPhosphoproteinPolymorphismRepeatTranscriptionTranscription regulationUbl conjugationTTATIMVTIRKHQATSASASAKSERGIISSAVITVIST
MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI
O95477Q96S56Q96T85Q9NQV4Q9UN06Q9UN07Q9UN08Q9UN09ABCA1_HUMANATP-binding cassette sub-family A member 1ATP-binding cassette transporter 1ATP-binding cassette 1ABC-1Cholesterol efflux regulatory proteinABCA1ABC1CERPHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoComplete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter.NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]ABCA1 gene expression and apoA-I-mediated cholesterol efflux are regulated by LXR.NUCLEOTIDE SEQUENCESkinHuman and mouse ABCA1 comparative sequencing and transgenesis studies revealing novel regulatory sequences.NUCLEOTIDE SEQUENCE [GENOMIC DNA]A new topological model of functional human ABCA1-signal peptide cleavage and glycosylation of a large extracellular domain.NUCLEOTIDE SEQUENCEMolecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.NUCLEOTIDE SEQUENCE [MRNA] OF 21-2261Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 21-2261Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux.PHOSPHORYLATION AT SER-1042 AND SER-2054The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux.REPRESSION BY ZNF202Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway.INDUCTION BY LIPOPOLYSACCHARIDECooperation between engulfment receptors: the case of ABCA1 and MEGF10.INTERACTION WITH MEGF10Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene.REVIEW ON VARIANTSMutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.VARIANTS HDLD2 THR-1091 AND 1893-GLU-ASP-1894 DELMutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.VARIANTS HDLD1 ARG-597 AND ARG-1477VARIANT HDLD2 LEU-693 DELThe gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.VARIANTS HDLD1 SER-590; SER-935 AND VAL-937VARIANTS ALA-399 AND MET-883Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.VARIANTS HDLD1 ARG-597; ILE-929 AND ARG-1477VARIANTS HDLD2 LEU-693 DEL; THR-1091; 1893-GLU-ASP-1894 DEL AND LEU-2150Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds.VARIANTS HDLD1 ASN-1289 AND HIS-1800Common and rare ABCA1 variants affecting plasma HDL cholesterol.VARIANT HDLD1 ASP-1046VARIANT HDLD2 CYS-230VARIANTS LYS-219; ILE-825; MET-883 AND LYS-1587A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease.VARIANT HDLD1 TRP-587VARIANT LEU-2168Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease.VARIANTS LYS-219; MET-883 AND ASP-1172Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome.VARIANT HDLD1 LEU-1506Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease.VARIANTS HDLD1 ASN-1289 AND TRP-2081VARIANT LYS-219Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.VARIANTS LYS-219; ALA-399; MET-771; PRO-774; ASN-776; ILE-825; MET-883; ASP-1172; LYS-1587 AND CYS-1731ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease.VARIANT HDLD2 LEU-85Novel ABCA1 compound variant associated with HDL cholesterol deficiency.VARIANT HDLD2 TYR-1099Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.VARIANT HDLD1 THR-255VARIANT ATHEROSCLEROSIS ASP-1611Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.VARIANTS LYS-219; MET-771; ILE-825; MET-883; ASP-1172; PHE-1181 AND LYS-1587A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.VARIANT LYS-219The consensus coding sequences of human breast and colorectal cancers.VARIANTS [LARGE SCALE ANALYSIS] ASP-210; TYR-917; THR-1407 AND THR-2109cAMP-dependent and sulfonylurea-sensitive anion transporter. Key gatekeeper influencing intracellular cholesterol transport.Interacts with MEGF10.O15085false1Q9NZN5false1Q15700false1Q92796false1Q9Z250true1Q9HAP6false1O88952true1O75970false1Q13424false1Q13884false2Widely expressed, but most abundant in macrophages.By bacterial lipopolysaccharides (LPS). LPS regulates expression through a liver X receptor (LXR) -independent mechanism. Repressed by ZNF202.Multifunctional polypeptide with two homologous halves, each containing an hydrophobic membrane-anchoring domain and an ATP binding cassette (ABC) domain.Phosphorylation on Ser-2054 regulates phospholipid efflux.Defects in ABCA1 are a cause of high density lipoprotein deficiency type 1 (HDLD1) [MIM:205400]; also known as analphalipoproteinemia or Tangier disease (TGD). HDLD1 is a recessive disorder characterized by absence of high density lipoprotein (HDL) cholesterol from plasma, accumulation of cholesteryl esters, premature coronary artery disease (CAD), hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness{EC3,EC4,EC5,EC6,EC7,EC8,EC9,EC10,EC11}.Defects in ABCA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) [MIM:604091]; also known as familial hypoalphalipoproteinemia (FHA). HDLD2 is inherited as autosomal dominant trait. It is characterized by moderately low HDL cholesterol, predilection toward premature coronary artery disease (CAD) and a reduction in cellular cholesterol efflux.Belongs to the ABC transporter family. ABCA subfamily.Contains 2 ABC transporter domains.The Singapore human mutation and polymorphism databaseAtherosclerosisATP-bindingCholesterol metabolismDisease mutationGlycoproteinLipid metabolismMembraneNucleotide-bindingPhosphoproteinPolymorphismRepeatSteroid metabolismTransmembraneTransportPLEDRKRCATVARWWSQRVMTPKNVIIMDYTINSAVADMTDYEDSFDNATCRSLIRTIRKNDPLSCNHRWATPLPLYCDNEK
MACWPQLRLLLWKNLTFRRRQTCQLLLEVAWPLFIFLILISVRLSYPPYEQHECHFPNKAMPSAGTLPWVQGIICNANNPCFRYPTPGEAPGVVGNFNKSIVARLFSDARRLLLYSQKDTSMKDMRKVLRTLQQIKKSSSNLKLQDFLVDNETFSGFLYHNLSLPKSTVDKMLRADVILHKVFLQGYQLHLTSLCNGSKSEEMIQLGDQEVSELCGLPREKLAAAERVLRSNMDILKPILRTLNSTSPFPSKELAEATKTLLHSLGTLAQELFSMRSWSDMRQEVMFLTNVNSSSSSTQIYQAVSRIVCGHPEGGGLKIKSLNWYEDNNYKALFGGNGTEEDAETFYDNSTTPYCNDLMKNLESSPLSRIIWKALKPLLVGKILYTPDTPATRQVMAEVNKTFQELAVFHDLEGMWEELSPKIWTFMENSQEMDLVRMLLDSRDNDHFWEQQLDGLDWTAQDIVAFLAKHPEDVQSSNGSVYTWREAFNETNQAIRTISRFMECVNLNKLEPIATEVWLINKSMELLDERKFWAGIVFTGITPGSIELPHHVKYKIRMDIDNVERTNKIKDGYWDPGPRADPFEDMRYVWGGFAYLQDVVEQAIIRVLTGTEKKTGVYMQQMPYPCYVDDIFLRVMSRSMPLFMTLAWIYSVAVIIKGIVYEKEARLKETMRIMGLDNSILWFSWFISSLIPLLVSAGLLVVILKLGNLLPYSDPSVVFVFLSVFAVVTILQCFLISTLFSRANLAAACGGIIYFTLYLPYVLCVAWQDYVGFTLKIFASLLSPVAFGFGCEYFALFEEQGIGVQWDNLFESPVEEDGFNLTTSVSMMLFDTFLYGVMTWYIEAVFPGQYGIPRPWYFPCTKSYWFGEESDEKSHPGSNQKRISEICMEEEPTHLKLGVSIQNLVKVYRDGMKVAVDGLALNFYEGQITSFLGHNGAGKTTTMSILTGLFPPTSGTAYILGKDIRSEMSTIRQNLGVCPQHNVLFDMLTVEEHIWFYARLKGLSEKHVKAEMEQMALDVGLPSSKLKSKTSQLSGGMQRKLSVALAFVGGSKVVILDEPTAGVDPYSRRGIWELLLKYRQGRTIILSTHHMDEADVLGDRIAIISHGKLCCVGSSLFLKNQLGTGYYLTLVKKDVESSLSSCRNSSSTVSYLKKEDSVSQSSSDAGLGSDHESDTLTIDVSAISNLIRKHVSEARLVEDIGHELTYVLPYEAAKEGAFVELFHEIDDRLSDLGISSYGISETTLEEIFLKVAEESGVDAETSDGTLPARRNRRAFGDKQSCLRPFTEDDAADPNDSDIDPESRETDLLSGMDGKGSYQVKGWKLTQQQFVALLWKRLLIARRSRKGFFAQIVLPAVFVCIALVFSLIVPPFGKYPSLELQPWMYNEQYTFVSNDAPEDTGTLELLNALTKDPGFGTRCMEGNPIPDTPCQAGEEEWTTAPVPQTIMDLFQNGNWTMQNPSPACQCSSDKIKKMLPVCPPGAGGLPPPQRKQNTADILQDLTGRNISDYLVKTYVQIIAKSLKNKIWVNEFRYGGFSLGVSNTQALPPSQEVNDATKQMKKHLKLAKDSSADRFLNSLGRFMTGLDTRNNVKVWFNNKGWHAISSFLNVINNAILRANLQKGENPSHYGITAFNHPLNLTKQQLSEVAPMTTSVDVLVSICVIFAMSFVPASFVVFLIQERVSKAKHLQFISGVKPVIYWLSNFVWDMCNYVVPATLVIIIFICFQQKSYVSSTNLPVLALLLLLYGWSITPLMYPASFVFKIPSTAYVVLTSVNLFIGINGSVATFVLELFTDNKLNNINDILKSVFLIFPHFCLGRGLIDMVKNQAMADALERFGENRFVSPLSWDLVGRNLFAMAVEGVVFFLITVLIQYRFFIRPRPVNAKLSPLNDEDEDVRRERQRILDGGGQNDILEIKELTKIYRRKRKPAVDRICVGIPPGECFGLLGVNGAGKSSTFKMLTGDTTVTRGDAFLNKNSILSNIHEVHQNMGYCPQFDAITELLTGREHVEFFALLRGVPEKEVGKVGEWAIRKLGLVKYGEKYAGNYSGGNKRKLSTAMALIGGPPVVFLDEPTTGMDPKARRFLWNCALSVVKEGRSVVLTSHSMEECEALCTRMAIMVNGRFRCLGSVQHLKNRFGDGYTIVVRIAGSNPDLKPVQDFFGLAFPGSVPKEKHRNMLQYQLPSSLSSLARIFSILSQSKKRLHIEDYSVSQTTLDQVFVNFAKDQSDDDHLKDLSLHKNQTVVDVAVLTSFLQDEKVKESYV
P22460Q4KKT8Q4VAJ1Q4VAJ2KCNA5_HUMANPotassium voltage-gated channel subfamily A member 5Voltage-gated potassium channel subunit Kv1.5HK2HPCN1KCNA5Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoMolecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle.NUCLEOTIDE SEQUENCE [MRNA]HeartSequence and functional expression in Xenopus oocytes of a human insulinoma and islet potassium channel.NUCLEOTIDE SEQUENCE [MRNA]InsulinomaMolecular cloning, characterization, and genomic localization of a human potassium channel gene.NUCLEOTIDE SEQUENCE [MRNA]HeartThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]The consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] SER-300Mediates the voltage-dependent potassium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a potassium-selective channel through which potasssium ions may pass in accordance with their electrochemical gradient. May play a role in regulating the secretion of insulin in normal pancreatic islets.Heterotetramer of potassium channel proteins. Interacts via its PDZ-binding motif with DLG1. Forms a ternary complex with DLG1 and CAV3.Membrane; Multi-pass membrane protein.Pancreatic islets and insulinoma.The amino terminus may be important in determining the rate of inactivation of the channel while the C-terminal PDZ-binding motif may play a role in modulation of channel activity and/or targeting of the channel to specific subcellular compartments.The segment S4 is probably the voltage-sensor and is characterized by a series of positively charged amino acids at every third position.Belongs to the potassium channel family. A (Shaker) subfamily.GlycoproteinIon transportIonic channelLipoproteinMembranePalmitatePhosphoproteinPolymorphismPotassiumPotassium channelPotassium transportRepeatTransmembraneTransportVoltage-gated channelGSLQRPRPGRGPVLVPAGSCPLEKCNVKAKSNVDLRRSLYALCLDTSRETDLQLPPREV
MEIALVPLENGGAMTVRGGDEARAGCGQATGGELQCPPTAGLSDGPKEPAPKGRGAQRDADSGVRPLPPLPDPGVRPLPPLPEELPRPRRPPPEDEEEEGDPGLGTVEDQALGTASLHHQRVHINISGLRFETQLGTLAQFPNTLLGDPAKRLRYFDPLRNEYFFDRNRPSFDGILYYYQSGGRLRRPVNVSLDVFADEIRFYQLGDEAMERFREDEGFIKEEEKPLPRNEFQRQVWLIFEYPESSGSARAIAIVSVLVILISIITFCLETLPEFRDERELLRHPPAPHQPPAPAPGANGSGVMAPPSGPTVAPLLPRTLADPFFIVETTCVIWFTFELLVRFFACPSKAGFSRNIMNIIDVVAIFPYFITLGTELAEQQPGGGGGGQNGQQAMSLAILRVIRLVRVFRIFKLSRHSKGLQILGKTLQASMRELGLLIFFLFIGVILFSSAVYFAEADNQGTHFSSIPDAFWWAVVTMTTVGYGDMRPITVGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETDHEEPAVLKEEQGTQSQGPGLDRGVQRKVSGSRGSFCKAGGTLENADSARRGSCPLEKCNVKAKSNVDLRRSLYALCLDTSRETDL
O15530PDPK1_HUMAN3-phosphoinositide-dependent protein kinase 1hPDK1PDPK1PDK1Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCharacterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)3-phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3)MyeloidThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)KidneyTranslocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B.MUTAGENESIS OF ARG-474ALTERNATIVE SPLICINGPhosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo.PHOSPHORYLATION AT SER-25; SER-241; SER-393; SER-396 AND SER-410MUTAGENESIS OF SER-25; SER-241; SER-393; SER-396 AND SER-410A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans.MUTAGENESIS OF ALA-277Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 (PDK1) and their role in regulating kinase activity.PHOSPHORYLATION AT TYR-9; SER-241; TYR-373 AND TYR-376MUTAGENESIS OF TYR-9; TYR-373 AND TYR-376Large-scale characterization of HeLa cell nuclear phosphoproteins.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241MASS SPECTROMETRYEpitheliumGlobal, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-245MASS SPECTROMETRYEpitheliumPhosphoproteomic analysis of the human pituitary.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241MASS SPECTROMETRYPituitaryPhosphorylates and activates not only PKB/AKT, but also PKA, PKC-zeta, RPS6KA1 and RPS6KB1. May play a general role in signaling processes and in development (By similarity). Isoform 3 is catalytically inactive.ATP + a protein = ADP + a phosphoprotein.Cytoplasm. Membrane; Peripheral membrane protein. Note=Membrane-associated after cell stimulation leading to its translocation. Tyrosine phosphorylation seems to occur only at the plasma membrane.O15530-11O15530-22O15530-33Appears to be expressed ubiquitously.Phosphorylated on tyrosine and serine/threonine. Phosphorylation on Ser-241 in the activation loop is required for full activity. PDK1 itself can autophosphorylate Ser-241, leading to its own activation.Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PDK1 subfamily.Contains 1 PH domain.Contains 1 protein kinase domain.3D-structureAlternative splicingATP-bindingCytoplasmKinaseMembraneNucleotide-bindingPhosphoproteinSerine/threonine-protein kinaseTransferaseYFSASAAVYFYFSASASARA
MARTTSQLYDAVPIQSSVVLCSCPSPSMVRTQTESSTPPGIPGGSRQGPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDEDCYGNYDNLLSQFGCMQVSSSSSSHSLSASDTGLPQRSGSNIEQYIHDLDSNSFELDLQFSEDEKRLLLEKQAGGNPWHQFVENNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEVWRQRYQSHPDAAVQ
Q92934O14803BAD_HUMANBcl2 antagonist of cell deathBADBcl-2-binding component 6Bcl-XL/Bcl-2-associated death promoterBcl-2-like 8 proteinBADBBC6BCL2L8Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoA human protein that interacts with Bcl-2 and have homology to mouse BAD.NUCLEOTIDE SEQUENCE [MRNA]Bcl-2 targets the protein kinase Raf-1 to mitochondria.NUCLEOTIDE SEQUENCE [MRNA]PHOSPHORYLATION BY RAF-1NUCLEOTIDE SEQUENCE [MRNA]Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.NUCLEOTIDE SEQUENCE [MRNA]DIMERIZATIONBone marrowCloning of human full-length CDSs in BD Creator(TM) system donor vector.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]LungRationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.STRUCTURE BY NMR OF 103-127Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways.Forms heterodimers with the anti-apoptotic proteins, Bcl-X(L), Bcl-2 and Bcl-W. Also binds protein S100A10 (By similarity). The Ser-75/Ser-99 phosphorylated form binds 14-3-3 proteins.P10415false3Q07817-1false3Q92843false1O60238false1P62136false1Mitochondrion outer membrane. Cytoplasm. Note=Upon phosphorylation, locates to the cytoplasm.Expressed in a wide variety of tissues.Intact BH3 motif is required by BIK, BID, BAK, BAD and BAX for their pro-apoptotic activity and for their interaction with anti-apoptotic members of the Bcl-2 family.Phosphorylated on one or more of Ser-75, Ser-99, Ser-118 and Ser-134 in response to survival stimuli, which blocks its pro-apoptotic activity. Phosphorylation on Ser-99 or Ser-75 promotes heterodimerization with 14-3-3 proteins. This interaction then facilitates the phosphorylation at Ser-118, a site within the BH3 motif, leading to the release of Bcl-X(L) and the promotion of cell survival. Ser-99 is the major site of AKT/PKB phosphorylation, Ser-118 the major site of protein kinase A (CAPK) phosphorylation.Belongs to the Bcl-2 family.Bcl 2-associated death promoter entry3D-structureApoptosisCytoplasmMembraneMitochondrionPhosphoproteinPolymorphismAS
MFQIPEFEPSEQEDSSSAERGLGPSPAGDGPSGSGKHHRQAPGLLWDASHQQEQPTSSSHHGGAGAVEIRSRHSSYPAGTEDDEGMGEEPSPFRGRSRSAPPNLWAAQRYGRELRRMSDEFVDSFKKGLPRPKSAGTATQMRQSSSWTRVFQSWWDRNLGRGSSAPSQ
Q93100Q8N4T5KPBB_HUMANPhosphorylase b kinase regulatory subunit betaPhosphorylase kinase subunit betaPHKBHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoStructure of the human gene encoding the phosphorylase kinase beta subunit (PHKB).NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]ALTERNATIVE SPLICINGThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)UterusAutosomal recessive phosphorylase kinase deficiency in liver, caused by mutations in the gene encoding the beta subunit (PHKB).VARIANT CYS-770Phosphorylase-kinase-deficient liver glycogenosis with an unusual biochemical phenotype in blood cells associated with a missense mutation in the beta subunit gene (PHKB).VARIANT GSD9B PRO-118Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases.VARIANTS LYS-657 AND CYS-770The consensus coding sequences of human breast and colorectal cancers.VARIANTS [LARGE SCALE ANALYSIS] VAL-867 AND ARG-877Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The beta chain acts as a regulatory unit and modulates the activity of the holoenzyme in response to phosphorylation.By phosphorylation of various serine residues.Glycan biosynthesis; glycogen metabolism.Polymer of 16 chains, four each of alpha, beta, gamma, and delta. Alpha and beta are regulatory chains, gamma is the catalytic chain, and delta is calmodulin.Cell membrane; Lipid-anchor; Cytoplasmic side .Q93100-11Q93100-22Q93100-33Q93100-44Defects in PHKB are the cause of glycogen storage disease type 9B (GSD9B) [MIM:261750]; also known as phosphorylase kinase deficiency of liver and muscle (PKD). GSD9B is a metabolic disorder characterized by hepathomegaly, only slightly elevated transaminases and plasma lipids, clinical improvement with increasing age, and remarkably no clinical muscle involvement. Biochemical observations suggest that this mild phenotype is caused by an incomplete holoenzyme that lacks the beta subunit, but that may possess residual activity.Belongs to the phosphorylase b kinase regulatory chain family.AcetylationAlternative splicingCalmodulin-bindingCarbohydrate metabolismDisease mutationGlycogen metabolismGlycogen storage diseaseLipoproteinMembranePhosphoproteinPolymorphismPrenylationMAGAAGLTAEVSWKVLERRARTKMACSPDAVVSPSSA FLLAVRYGAAFTQKFSSSIAPHITTFLVHSVVRRAASLL SKVVDSLAPSITNVLVQAPQKYCEVLVGR
MAGAAGLTAEVSWKVLERRARTKRSGSVYEPLKSINLPRPDNETLWDKLDHYYRIVKSTLLLYQSPTTGLFPTKTCGGDQKAKIQDSLYCAAGAWALALAYRRIDDDKGRTHELEHSAIKCMRGILYCYMRQADKVQQFKQDPRPTTCLHSVFNVHTGDELLSYEEYGHLQINAVSLYLLYLVEMISSGLQIIYNTDEVSFIQNLVFCVERVYRVPDFGVWERGSKYNNGSTELHSSSVGLAKAALEAINGFNLFGNQGCSWSVIFVDLDAHNRNRQTLCSLLPRESRSHNTDAALLPCISYPAFALDDEVLFSQTLDKVVRKLKGKYGFKRFLRDGYRTSLEDPNRCYYKPAEIKLFDGIECEFPIFFLYMMIDGVFRGNPKQVQEYQDLLTPVLHHTTEGYPVVPKYYYVPADFVEYEKNNPGSQKRFPSNCGRDGKLFLWGQALYIIAKLLADELISPKDIDPVQRYVPLKDQRNVSMRFSNQGPLENDLVVHVALIAESQRLQVFLNTYGIQTQTPQQVEPIQIWPQQELVKAYLQLGINEKLGLSGRPDRPIGCLGTSKIYRILGKTVVCYPIIFDLSDFYMSQDVFLLIDDIKNALQFIKQYWKMHGRPLFLVLIREDNIRGSRFNPILDMLAALKKGIIGGVKVHVDRLQTLISGAVVEQLDFLRISDTEELPEFKSFEELEPPKHSKVKRQSSTPSAPELGQQPDVNISEWKDKPTHEILQKLNDCSCLASQAILLGILLKREGPNFITKEGTVSDHIERVYRRAGSQKLWLAVRYGAAFTQKFSSSIAPHITTFLVHGKQVTLGAFGHEEEVISNPLSPRVIQNIIYYKCNTHDEREAVIQQELVIHIGWIISNNPELFSGMLKIRIGWIIHAMEYELQIRGGDKPALDLYQLSPSEVKQLLLDILQPQQNGRCWLNRRQIDGSLNRTPTGFYDRVWQILERTPNGIIVAGKHLPQQPTLSDMTMYEMNFSLLVEDTLGNIDQPQYRQIVVELLMVVSIVLERNPELEFQDKVDLDRLVKEAFNEFQKDQSRLKEIEKQDDMTSFYNTPPLGKRGTCSYLTKAVMNLLLEGEVKPNNDDPCLIS
Q96PU5O43165Q7Z5F1Q7Z5F2Q7Z5N3Q8N5A7Q8WUU9Q9BW58Q9H2W4Q9NT88NED4L_HUMANE3 ubiquitin-protein ligase NEDD4-like proteinNedd4-2NEDD4.2NEDD4LKIAA0439NEDL3Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoNEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)ALTERNATIVE SPLICINGIdentification of new partners of the epithelial sodium channel alpha subunit.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)INTERACTION WITH SCNN1A; SCNN1B AND SCNN1GKidneyAndrogens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 6 AND 7)TISSUE SPECIFICITYINDUCTIONProstateHomo sapiens NEDD4-like ubiquitin ligase 3.NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 101-975 (ISOFORM 5)SkinUterusPrediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 8)BrainNUCLEOTIDE SEQUENCE [MRNA] OF 52-975 (ISOFORM 3)Testis14-3-3 proteins modulate the expression of epithelial Na+ channels by phosphorylation-dependent interaction with Nedd4-2 ubiquitin ligase.PROTEIN SEQUENCE OF 448-462INTERACTION WITH YWHAB; YWHAG; YWHAE; YWHAQ AND YWHAHPHOSPHORYLATION AT SER-448MUTAGENESIS OF SER-448MASS SPECTROMETRYLatent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.INTERACTION WITH EPSTEIN-BARR VIRUS LMP2ASerum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+ channel.INTERACTION WITH SGK AND SCNN1APHOSPHORYLATIONN4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein.INTERACTION WITH NDFIP1Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms SGK1/3 and protein kinase B.FUNCTIONCardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination.FUNCTIONMUTAGENESIS OF CYS-942INTERACTION WITH SCN5ANedd4-2 functionally interacts with ClC-5: involvement in constitutive albumin endocytosis in proximal tubule cells.FUNCTIONINTERACTION WITH CLCN5INDUCTIONcAMP and serum and glucocorticoid-inducible kinase (SGK) regulate the epithelial Na(+) channel through convergent phosphorylation of Nedd4-2.PHOSPHORYLATION AT SER-342; THR-367 AND SER-448Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1.FUNCTIONMolecular determinants of voltage-gated sodium channel regulation by the Nedd4/Nedd4-like proteins.INTERACTION WITH SCN2A; SCN3A AND SCN5ANEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.FUNCTIONINTERACTION WITH SMAD2; SMAD3; SMAD6 AND SMAD7SUBCELLULAR LOCATIONTISSUE SPECIFICITYNedd4-2 phosphorylation induces serum and glucocorticoid-regulated kinase (SGK) ubiquitination and degradation.FUNCTIONGlobal, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-479; SER-483 AND SER-487MASS SPECTROMETRYEpitheliumA naturally occurring human Nedd4-2 variant displays impaired ENaC regulation in Xenopus laevis oocytes.VARIANTS LEU-355 AND ARG-497E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Inhibits TGF-beta signaling by triggering SMAD2 and TGFR1 ubiquitination and proteasome-dependent degradation. Promotes ubiquitination and internalization of various plasma membrane channels such as ENaC, Nav1.2, Nav1.3, Nav1.5, Nav1.7, Nav1.8, Kv1.3, EAAT1 or CLC5. Promotes ubiquitination and degradation of SGK.Protein degradation; protein ubiquitinylation.Interacts with NDFIP2 and UBE2E3 (By similarity). Interacts via its WW domains with SCNN1A, SCNN1B, SCNN1G, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SCN10A and CLCN5. Interacts with SMAD2, SMAD3, SMAD6 and SMAD7. The phosphorylated form interacts with 14-3-3 proteins. Interacts with Epstein-Barr virus LMP2A. Interacts with NDFIP1 in vitro.Cytoplasm.Q96PU5-11Nedd4-2cQ96PU5-22No experimental confirmation availableQ96PU5-33NEDD4LeNo experimental confirmation availableQ96PU5-44NEDD4La,NEDD4Lb,NEDD4LfQ96PU5-55NEDD4LdQ96PU5-66NEDD4LhQ96PU5-77NEDD4LgQ96PU5-88NEDD4Lc,Nedd4-2aIncomplete sequenceUbiquitously expressed, with highest levels in prostate, pancreas and kidney.By androgens in prostate, and by albumin in kidney.Phosphorylated by SGK or PKA; which impairs interaction with SCNN. Interaction with YWHAH inhibits dephosphorylation.Contains 1 C2 domain.Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.Contains 4 WW domains.3D-structureAlternative splicingCytoplasmDirect protein sequencingHost-virus interactionLigasePhosphoproteinPolymorphismRepeatUbl conjugation pathwayMATGLGEPVYGLSEDEGESRILRVKVVSGIDLAKKDIFGASPGGWLRRALPGRERLQSPVHAVPPQHGTSHSRLLVTWP GAGRDQDFSSPPLLLLGETDHLHLDLPLSPLPTSDELFLPG ICMATGLGEPVYGLSEDEMRRLAFEQPLSRSACSAPEK
MATGLGEPVYGLSEDEGESRILRVKVVSGIDLAKKDIFGASDPYVKLSLYVADENRELALVQTKTIKKTLNPKWNEEFYFRVNPSNHRLLFEVFDENRLTRDDFLGQVDVPLSHLPTEDPTMERPYTFKDFLLRPRSHKSRVKGFLRLKMAYMPKNGGQDEENSDQRDDMEHGWEVVDSNDSASQHQEELPPPPLPPGWEEKVDNLGRTYYVNHNNRTTQWHRPSLMDVSSESDNNIRQINQEAAHRRFRSRRHISEDLEPEPSEGGDVPEPWETISEEVNIAGDSLGLALPPPPASPGSRTSPQELSEELSRRLQITPDSNGEQFSSLIQREPSSRLRSCSVTDAVAEQGHLPPPSAPAGRARSSTVTGGEEPTPSVAYVHTTPGLPSGWEERKDAKGRTYYVNHNNRTTTWTRPIMQLAEDGASGSATNSNNHLIEPQIRRPRSLSSPTVTLSAPLEGAKDSPVRRAVKDTLSNPQSPQPSPYNSPKPQHKVTQSFLPPGWEMRIAPNGRPFFIDHNTKTTTWEDPRLKFPVHMRSKTSLNPNDLGPLPPGWEERIHLDGRTFYIDHNSKITQWEDPRLQNPAITGPAVPYSREFKQKYDYFRKKLKKPADIPNRFEMKLHRNNIFEESYRRIMSVKRPDVLKARLWIEFESEKGLDYGGVAREWFFLLSKEMFNPYYGLFEYSATDNYTLQINPNSGLCNEDHLSYFTFIGRVAGLAVFHGKLLDGFFIRPFYKMMLGKQITLNDMESVDSEYYNSLKWILENDPTELDLMFCIDEENFGQTYQVDLKPNGSEIMVTNENKREYIDLVIQWRFVNRVQKQMNAFLEGFTELLPIDLIKIFDENELELLMCGLGDVDVNDWRQHSIYKNGYCPNHPVIQWFWKAVLLMDAEKRIRLLQFVTGTSRVPMNGFAELYGSNGPQLFTIEQWGSPEKLPRAHTCFNRLDLPPYETFEDLREKLLMAVENAQGFEGVD
P60853LZTS1_MOUSELeucine zipper putative tumor suppressor 1F37/Esophageal cancer-related gene-coding leucine-zipper motifFez1Lzts1Fez1Mus musculusMouseEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMusThe FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.NUCLEOTIDE SEQUENCE [MRNA]129/JInvolved in the regulation of cell growth. May stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. May act as tumor suppressor.Binds EEF1G and CDC2.Cytoplasm (By similarity). Cell membrane (By similarity). Cell projection, dendritic spine (By similarity). Cell junction, synapse, postsynaptic cell membrane, postsynaptic density (By similarity). Cell junction, synapse (By similarity). Note=Associated with the plasma membrane and with microtubules. Detected in dendritic spines, especially in the postsynaptic density.Phorphorylated on serine residues. Hyperphosphorylated by the cAMP-dependent kinase PKA during cell-cycle progression.Belongs to the LZTS family.Anti-oncogeneCell cycleCell junctionCell projectionCoiled coilCytoplasmLipoproteinMembraneMyristatePhosphoproteinPostsynaptic cell membraneSynapse
MGSVSSLISGHSFHSKHCRASQYKLRKSSHLKKLNRYSDGLLRFGFSQDSGRGKSSSKMGKSEDFFYIKVSQKARGSHRPDYTALSSGDMGGQTGVDFDPATPPKLMPFSNQLEMSSDKGAVRPTAFKPVLPRSGAILHSSPESTSHQLHPMPPDKPKEQELKPGLCSGALSDSGRNSMSSLPTHSTTSSYQLDPLVTPVGPTSRFGGSAHNITQGIILQDSNMMSLKALSFSDGGSKLAHPGKADKGASCVRSPLSTDECTIQELEQKLLQRETALQKLQRSFDEKEFASGQTFEERPRRTRDELECLEPKSKLKPPSQKSQRTQQVLQLQVLQLQQEKRQLRQELESLMKEQDLLETKLRSYEREKTNFAPALEETQWEVCQKSGEISLLKQQLKESQLEVNTKASEILSLKAQLKDTRGKLDGMELKTQDLESALRTKGLELEVCENELQRKKNEAELLREKVNLLEQELMELRAQAALHPAPLGPPGVGLTFSEDIPALQRELDRLRAELKEERQGHDQMSSGFQHERLVWKEEKEKVIQYQRQLQQSYLAMYQRNQRLEKALQQLARGDGPGEPFEIDLEGADIPYEDIIATEI
Q7Z6R9Q8IWX0AP2D_HUMANTranscription factor AP-2 deltaAP2-deltaActivating enhancer-binding protein 2 deltaTranscription factor AP-2 beta-like 1TFAP2DTFAP2BL1Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoCloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1).NUCLEOTIDE SEQUENCE [MRNA]TISSUE SPECIFICITYThe DNA sequence and analysis of human chromosome 6.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]The consensus coding sequences of human breast and colorectal cancers.VARIANT [LARGE SCALE ANALYSIS] PHE-214Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC.Binds DNA as a dimer. Can form homodimers or heterodimers with other AP-2 family members.Nucleus.Highly expressed in brain, placenta, skeletal muscle, thymus, small intestine, and prostate, and expressed at lower levels in leukocyte, spleen, testis, ovary and colon. Barely detectable in heart, kidney, liver, lung or pancreas.Belongs to the AP-2 family.Activatin protein 2 entryActivatorDNA-bindingNucleusPhosphoproteinPolymorphismTranscriptionTranscription regulationVFHYSN
MSTTFPGLVHDAEIRHDGSNSYRLMQLGCLESVANSTVAYSSSSPLTYSTTGTEFASPYFSTNHQYTPLHHQSFHYEFQHSHPAVTPDAYSLNSLHHSQQYYQQIHHGEPTDFINLHNARALKSSCLDEQRRELGCLDAYRRHDLSLMSHGSQYGMHPDQRLLPGPSLGLAAAGADDLQGSVEAQCGLVLNGQGGVIRRGGTCVVNPTDLFCSVPGRLSLLSSTSKYKVTIAEVKRRLSPPECLNASLLGGILRRAKSKNGGRCLREKLDRLGLNLPAGRRKAANVTLLTSLVEGEALHLARDFGYTCETEFPAKAVGEHLARQHMEQKEQTARKKMILATKQICKEFQDLLSQDRSPLGSSRPTPILDLDIQRHLTHFSLITHGFGTPAICAALSTFQTVLSEMLNYLEKHTTHKNGGAADSGQGHANSEKAPLRKTSEAAVKEGKTEKTD
Q96T88Q8J022Q9H6S6Q9P115Q9P1U7UHRF1_HUMANE3 ubiquitin-protein ligase UHRF1Ubiquitin-like PHD and RING finger domain-containing protein 1Ubiquitin-like-containing PHD and RING finger domains protein 1Inverted CCAAT box-binding protein of 90 kDaTranscription factor ICBP90Nuclear zinc finger protein Np95Nuclear protein 95HuNp95RING finger protein 106UHRF1ICBP90NP95RNF106Homo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIa expression.NUCLEOTIDE SEQUENCE [MRNA]TISSUE SPECIFICITYDEVELOPMENTAL STAGESUBCELLULAR LOCATIONDNA-BINDINGINDUCTIONFUNCTIONThymusLMO2-induced T cell leukemias overexpress Np95, a gene containing RING and PHD zinc fingers and an ubiquitin-like domain.NUCLEOTIDE SEQUENCE [MRNA]NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).NUCLEOTIDE SEQUENCE [GENOMIC DNA]VARIANTS HIS-240; LYS-379; THR-638; MET-642 AND PHE-713The DNA sequence and biology of human chromosome 19.NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]Complete sequencing and characterization of 21,243 full-length human cDNAs.NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 479-745Genomic structure and chromosomal mapping of the gene coding for huNp95, a protein involved in DNA repair and DNA replication processes.NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 607-745ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.INDUCTIONTISSUE SPECIFICITYPhosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.PHOSPHORYLATIONPHOSPHORYLATION AT SER-298MUTAGENESIS OF SER-298; SER-651 AND SER-666Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.INDUCTIONUBIQUITINATIONFUNCTIONICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.FUNCTIONINDUCTIONTISSUE SPECIFICITYDNA-BINDINGINTERACTION WITH HDAC1 AND UHRF1BP1Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287 AND SER-639MASS SPECTROMETRYEpitheliumA probability-based approach for high-throughput protein phosphorylation analysis and site localization.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-639MASS SPECTROMETRYEpitheliumTryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry.UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-385MASS SPECTROMETRYUbiquitin-like domain of human nuclear zinc finger protein NP95.X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-76Putative E3 ubiquitin-protein ligase. May participate in methylation-dependent transcriptional regulation. Binds to inverted 5'-CCAAT-3' box 2 in the TOP2A promoter, and activates TOP2A expression. Important for G1/S transition. May be involved in DNA repair and chromosomal stability.Protein degradation; protein ubiquitinylation.Interacts with histones H3, H1 and H2B (By similarity). Interacts with HDAC1, but not with HDAC2. Interacts with UHRF1BP1. Binds methylated CpG containing oligonucleotides.Nucleus.Expressed in thymus, bone marrow, testis, lung and heart. Overexpressed in breast cancer.Expressed in fetal thymus, liver and kidney.Up-regulated in proliferating cells, and down-regulated in quiescent cells. Down-regulated upon adriamycin-induced DNA damage, in a TP53/p53 and CDKN1A-dependent way. Induced by E2F1 transcription factor.The RING finger is required for ubiquitin ligase activity.The YDG domain mediates the interaction with histone H3.Phosphorylated on serine residues. Phosphorylation may enhance DNA-binding activity.Ubiquitinated; which leads to proteasomal degradation. Polyubiquitination may be stimulated by DNA damage.Contains 1 PHD-type zinc finger.Contains 2 RING-type zinc fingers.Contains 1 ubiquitin-like domain.Contains 1 YDG domain.3D-structureCell cycleDNA damageDNA repairDNA-bindingLigaseMetal-bindingNucleusPhosphoproteinPolymorphismTranscriptionTranscription regulationUbl conjugationUbl conjugation pathwayZincZinc-fingerDHEKATTMLFSASASAKNAS
MWIQVRTMDGRQTHTVDSLSRLTKVEELRRKIQELFHVEPGLQRLFYRGKQMEDGHTLFDYEVRLNDTIQLLVRQSLVLPHSTKERDSELSDTDSGCCLGQSESDKSSTHGEAAAETDSRPADEDMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERPGEGSPMVDNPMRRKSGPSCKHCKDDVNRLCRVCACHLCGGRQDPDKQLMCDECDMAFHIYCLDPPLSSVPSEDEWYCPECRNDASEVVLAGERLRESKKKAKMASATSSSQRDWGKGMACVGRTKECTIVPSNHYGPIPGIPVGTMWRFRVQVSESGVHRPHVAGIHGRSNDGAYSLVLAGGYEDDVDHGNFFTYTGSGGRDLSGNKRTAEQSCDQKLTNTNRALALNCFAPINDQEGAEAKDWRSGKPVRVVRNVKGGKNSKYAPAEGNRYDGIYKVVKYWPEKGKSGFLVWRYLLRRDDDEPGPWTKEGKDRIKKLGLTMQYPEGYLEALANREREKENSKREEEEQQEGGFASPRTGKGKWKRKSAGGGPSRAGSPRRTSKKTKVEPYSLTAQQSSLIREDKSNAKLWNEVLASLKDRPASGSPFQLFLSKVEETFQCICCQELVFRPITTVCQHNVCKDCLDRSFRAQVFSCPACRYDLGRSYAMQVNQPLQTVLNQLFPGYGNGR
P50552Q6PIZ1Q93035VASP_HUMANVasodilator-stimulated phosphoproteinVASPVASPHomo sapiensHumanEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomoMolecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP.NUCLEOTIDE SEQUENCE [MRNA]PROTEIN SEQUENCE OF 11-32; 87-96; 140-154; 255-282 AND 297-322SUBCELLULAR LOCATIONTISSUE SPECIFICITYPOSSIBLE FUNCTIONPromyelocyteRole of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes.NUCLEOTIDE SEQUENCE [MRNA]FUNCTIONINTERACTION WITH L.MONOCYTOGENES ACTAThe status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]Fetal lungFetal spleenSkinExploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.PROTEIN SEQUENCE OF 2-10ACETYLATION AT SER-2PlateletCloning of the VASP (vasodilator-stimulated phosphoprotein) genes in human and mouse: structure, sequence, and chromosomal localization.NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-380cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets.PROTEIN SEQUENCE OF 143-164; 235-244 AND 267-285PHOSPHORYLATION AT SER-157; SER-239 AND THR-278Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.PHOSPHORYLATION AT SER-157FIBRINOGEN RECEPTOR INHIBITIONThe proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins.INTERACTION WITH ACTG1 AND PFN1The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation.FUNCTION OF EVH2 DOMAINCharacterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins.INTERACTION WITH ZYXLPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity.INTERACTION WITH LPPLamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics.INTERACTION WITH RAPH1Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C.PHOSPHORYLATION BY PKCEna/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins.FUNCTIONImmunoaffinity profiling of tyrosine phosphorylation in cancer cells.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39MASS SPECTROMETRYVasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser 157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets.PHOSPHORYLATION AT SER-157SUBCELLULAR LOCATIONGlobal proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239MASS SPECTROMETRYThe VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat.X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 336-380TETRAMERIZATIONMUTAGENESIS OF PHE-370Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity.STRUCTURE BY NMR OF 1-115Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. VASP promotes actin nucleation and increases the rate of actin polymerization in the presence of capping protein. Plays a role in actin-based activity of Listeria monocytogenes in platelets.Homotetramer. Interacts with PFN1, PFN2, LPP, ACTN1 and ACTG1. Interacts, via the EVH1, with the Pro-rich regions of ZYX. This interaction is important for targeting to focal adhesions and the formation of actin-rich structures at the apical surface of cells. Interacts, via the EVH1 domain, with the Pro-rich domain of Listeria monocytogenes actA. Interacts with APBB1IP. Interacts, via the Pro-rich domain, with the C-terminal SH3 domain of DNMBP.Cytoplasm. Cytoplasm, cytoskeleton. Cell junction, focal adhesion. Cell projection, lamellipodium membrane. Cell projection, filopodium membrane. Note=Targeted to stress fibers and focal adhesions through interaction with a number of proteins including MRL family members. Localizes to the plasma membrane in protruding lamellipodia and filopodial tips. Stimulation by thrombin or PMA, also translocates VASP to focal adhesions.Highly expressed in platelets.The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization.Major substrate for cAMP-dependent (PKA) and cGMP-dependent protein kinase (PKG) in platelets. The preferred site for PKA is Ser-157, the preferred site for PKG, Ser-239. In ADP-activated platelets, phosphorylation by PKA or PKG on Ser-157 leads to fibrinogen receptor inhibition. Phosphorylation on Thr-278 requires prior phosphorylation on Ser-157 and Ser-239. In response to phorbol ester (PMA) stimulation, phosphorylated by PKC/PRKCA. In response to thrombin, phosphorylated by both PKC and ROCK1.Belongs to the Ena/VASP family.Contains 1 WH1 domain.3D-structureAcetylationActin-bindingCell junctionCell projectionCoiled coilCytoplasmCytoskeletonDirect protein sequencingMembranePhosphoproteinRepeatSH3-bindingFAFIKSSS
MSETVICSSRATVMLYDDGNKRWLPAGTGPQAFSRVQIYHNPTANSFRVVGRKMQPDQQVVINCAIVRGVKYNQATPNFHQWRDARQVWGLNFGSKEDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKRQQPGPSEHIERRVSNAGGPPAPPAGGPPPPPGPPPPPGPPPPPGLPPSGVPAAAHGAGGGPPPAPPLPAAQGPGGGGAGAPGLAAAIAGAKLRKVSKQEEASGGPTAPKAESGRSGGGGLMEEMNAMLARRRKATQVGEKTPKDESANQEEPEARVPAQSESVRRPWEKNSTTLPRMKSSSSVTTSETQPCTPSSSDYSDLQRVKQELLEEVKKELQKVKEEIIEAFVQELRKRGSP
Copyrighted by the UniProt Consortium, see
http://www.uniprot.org/terms.
Distributed under the Creative Commons Attribution-NoDerivs License.